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Directed cell migration is a ubiquitous phenomenon with implications in development, 
wound healing, immunity, and metastasis. The ability of cells to orient their migration is 
dependent on the presence of external cues, the components to detect them and the 
intracellular networks to process them. This dissertation explores how the regulation of 
core intracellular components can shape directional migration responses and the 
mechanisms in which cells decode single and multiple external guidance cues. Given the 
complexity and redundancy in migratory signaling pathways, we develop a new 
technique to generate an intracellular gradient of protein activity without receptor 
activation. We demonstrate the utility of this technique by imposing gradients of different 
values of the active form of one of the core mediators of directed migration, a Rho 
GTPase, Rac. We find that shallow gradients of Rac alone are sufficient to direct the 
polarity and movement of cells, recapitulating phenotypes of chemoattractant induced 
migration and demonstrating synthetic chemotaxis in mammalian cells. These results 
reveal that cell polarity can be defined starting from a downstream node, Rac. 
Furthermore, we present a new refined mathematical model of cell chemotaxis and 
suggest a novel role for an upstream kinase, PI3K, in sensitizing cells to Rac activation. 
Next, we explore how cells process multiple guidance inputs, chemotaxis and contact 
inhibition of locomotion (CIL), and the resulting implications for directed cell migration. 
We find that chemotaxis and CIL do not act independently, as the resulting migration 
phenotypes when both cues are presented in conjunction are altered when they are 
presented individually. The balance between these cues is dynamic; modulating the 
strength of the cues through external inputs or molecular interventions can influence the 
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resulting directed migration outcomes. We further investigate the mechanistic basis of 
this dependency by enumerating the molecular mediators of these cues and finding where 
they might crosstalk. In this study, we develop several new techniques at the interface 
between engineering and the life sciences and present their applications. We anticipate 
that similar multidisciplinary approaches will help unravel mysteries in directed cell 
migration and in general biology. 
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1.1 Directed migration in the developing and adult human 
 
 
 Directed cell migration is the ability of cells to sense, interpret and move towards 
or away from external stimuli. It is responsible for the proper function of a rich diversity 











, among many others. Therapeutic interests in this field lie in juxtaposition; 
methods to augment or reduce directed motility are both being sought after. For example, 
the enhancement or correction of directed migration is ideal for wound healing 
applications
6
 or an unresponsive immune system
7
. On the other hand, the abatement or 
blockage of directed migration is ideal for stopping the metastasis of cancer cells from 
primary tumor sites
8
 or in treating inflammatory disorders
9
. Thus a fine balance exists 
between the sensitivity and selectivity of cell migration toward attracting or repulsing 
stimuli. A common approach to understanding directed cell migration has been to identify 
and characterize the roles of signaling proteins involved in migration. Over the past two 
decades, the individual functions and localizations of many components regulating cell 
migration have been identified
10, 11
. A core circuit of proteins has been outlined with each 
protein having a respective role. However, recent work has shown that the roles of some 
canonical proteins may not be clear cut and may be context dependent
12-14
.  Additionally, 
alternative circuits have been discovered
15, 16
 indicating redundancy in the process and 
adding new layers of complexity to understanding directed migration. A given migratory 
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cue binding to receptors on the cell surface can activate multiple pathways that converge 
onto similar downstream outputs.  Thus the molecular basis of directed migration remains 
actively investigated.  In the subsequent sections, we will provide a general background 
into the field of directed migration, with a particular emphasis on single cell studies and 
techniques, as these areas are the primary focus of this dissertation. 
 
1.2  Environmental cues regulating directed cell migration 
 
 Given the abundance of processes which involve directed migration, it is not 
surprising that there are a plethora of cues which induce directional migration. Cues 
which induce directional migration are collectively referred to as “taxes”, which is plural 
for the word “taxis”, derived from the Greek word for arrangement
17
. The nomenclature 
of individual cues is acquired from the nature of the stimulus. For example, chemotaxis 
refers to directional migration in response to soluble chemicals while phototaxis refers to 
directional migration in response to light. Other directional migration cues include but are 









, and topography (topotaxis)
22
. The most well 
studied taxis is chemotaxis, which is a focus of this thesis. However, as biological assays 
and observation techniques have advanced, other cues have begun to be recognized as 
prominent players in directed migration.  It is important to note that these stimuli impart 
cellular guidance by being present in gradients, where concentrations or intensities vary 
across defined distances. Cellular guidance is achieved by detection of these gradations. 
Remarkably, single cells have the capacity to sense minute differences in cues across 
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their length and can subsequently migrate quite accurately
23
. This has lead to much 
fascination and speculation as to how this is achieved and has motivated the development 
of several model single cell systems.  
 
1.3  Directed migration in single cells- model systems 
 
 In the subsections below, we will detail several popular single cell model systems 
used to study directed cell migration. These single cell model systems can be grouped 
into categories based on speed- fast moving (dictyostelium, neutrophils) vs. slow moving 
(fibroblasts, cancer cells) and morphology- amoeboid (dictyostelium, neutrophils, some 
cancer cells) vs. mesenchymal (fibroblasts, some cancer cells). Further subdivisions can 
be made by distinguishing the mode of motility, for example, generation of propulsion 
via f-actin rich protrusions or actin devoid blebbing driven by actin-myosin contractions. 
It is important to note that these distinctions may not always be clear cut, as some cancer 
cells and fibroblasts have been shown to change their morphology and mode of motility 
depending upon their local environment
24, 25
. The above dichotomy, particularly 
migration speed, has necessitated the development of different assays to study directed 
migration to match the time scales of motility and/or physiological environments. Details 
of these assays and their relative merits will be discussed in the later sections. 
   




 Dictyostelium discoideum (Dd) are soil residing social amoebas which migrate 
towards folic acid or other nutrients while vegetative. Upon starvation, complex 
morphogenesis takes place, where single amoeba aggregate through attraction to 
paracrine secretions of cyclic adenosine monophosphate (cAMP), forming converging 
cellular streams leading to the development of multi-cellular slugs and eventually, 
fruiting bodies
26
. These innate behaviors make Dd an ideal system for studying 
chemotaxis, as each phase of the dyctostelium life cycle relies on the ability to home 
towards soluble chemicals. Dd can be maintained in laboratory culture with controlled 
medium supplementation and defined developmental stages. Experimentally, Dd are 
genetically tractable with phenotypes which are relatively simple to evaluate and 
manipulate
27
. Many of the chemotaxis signaling pathways delineated in dictyostelium are 
preserved in higher order eukaryotes
27
, thus making them suitable proxies for studying 
signal transduction. There are, however, notable differences between dictyostelium and 
mammalian cells, which must be kept in perspective when extrapolating results and 
conclusions. 
 
1.3.2  Neutrophils 
 
 Neutrophils are members of the innate immune system which home to sites of 
bacterial infection and inflammation. Their primary function is to eliminate pathogens 
through phagocytosis and subsequent treatment with reactive oxygen species or 
antibacterial proteins
28
. Proper neutrophil behavior is essential for homeostasis
7
, while 
improper behavior results in a host of autoimmune disorders
9
, such as rheumatoid 
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arthritis. A large subset of their physiological behavior relies on their ability to migrate 
rapidly and accurately to specific tissues, thus necessitating robust cue detection and 
cytoskeletal arrangement systems. Neutrophils migrate directionally towards a variety of 
chemoattractants, ranging from bacterial peptides to inflammatory chemokines
28
. Primary 
neutrophils can be isolated through various methods for biological studies, including 
centrifugation from peripheral blood and peritoneal fluid
29
. Alternatively, given that 
neutrophils are short lived
30
, an immortalized promyelocytic leukemia cell line, named 
HL-60, can be differentiated to become neutrophil like
31





1.3.3  Fibroblasts 
 
 Fibroblasts are mesenchymal cells critical to the wound healing process. After a 
post injury clot has formed from platelet aggregation, fibroblasts invade the wound clot, 
remodel the local matrix, and subsequently induce contractions which aid in 
reepithelialization
32
. Fibroblasts are normally quiescent, but are induced to proliferate and 
migrate directionally by mitogenic factors, with the most prominent factor being platelet 
derived growth factor (PDGF)
33
. Fibroblasts have also been shown to migrate towards 
extracellular matrix (ECM) components, such as collagen and fibronectin
33
. Many 
researchers have used primary mouse embryonic fibroblasts (MEFs) for 
experimentation
34
, while others have used the immortalized NIH 3T3 cell line
35
. As 
mentioned above, fibroblast migration is quite slow when compared to neutrophils or Dd, 
differing by about an order of magnitude (10 m/min for dictyostelium, 20 m/min for 
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neutrophils, and .5~1 m/min for fibroblasts
36
). Therefore, although many molecular 
players may be conserved among cell types, it is not surprising that fibroblasts have a 
distinct spatial detection mechanism and motility paradigm
36
. The above differences 
highlight the need to explore directed migration pathways in various cell types, as 
molecular interventions in one cell type may be ineffective in others. 
 
1.3.4 Cancer cells 
  
 The textbook image of cancer is a mass of cells at a primary tumor site. This cell 
aggregation is induced by the acquisition of cellular mutations which enhance 
proliferation and survival beyond normal homeostatic levels. When cancer cells remain 
localized to the primary tumor site, prognosis remains relatively high, as extraction of the 
tumor via surgical or other therapeutic means is effective. However, when cancer cells 
metastasize, that is, disseminate from the primary tumor site to secondary sites in the 
body, mortality dramatically increases
37
. Directed migration is an essential step in 
metastasis
38
, as it is involved in biasing cancer cell migration away from primary sites 
towards blood vessels, whereby subsequent intravasation into the blood stream promotes 
dissemination. Many cancer cells can migrate towards a variety of soluble factors, 
including chemokines and growth factors such as epidermal growth factor (EGF)
38
. The 
toolkit for studying directed migration in cancer cells revolves around the use of cancer 
cell lines for specific cancers. In this thesis, we will utilize a well characterized metastatic 
rat adenocarcinoma breast cancer cell line named MTLn3
39
, which migrate towards 
gradients of soluble EGF
40
.  As noted above for fibroblasts, MTLn3 cells and other 
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cancer cells contain distinct migration mechanisms, thus necessitating the elucidation of 
directed migration mechanisms in specific cell types of interest. 
 
1.4  Collective migration  
 
 In single cell directed migration described above, cell to cell contacts and 
interactions are transient or non-existent. These ephemeral interactions allow cells to 
remain autonomous, as is seen in fibroblasts and neutrophils in vivo and permit 
characteristic single file cell streams as observed in vivo for some metastasizing 
cancers
38
. However, collective cell migration, where cell contacts are maintained, is also 
quite prominent in directed migration. For example, in metastasizing cancer, multicellular 
strands are frequently observed invading the local tumor stroma
41
. Collective migration 
also plays prominent roles in development, for example, in gastrulation, and in 
reepithelialization during wound healing
42
. There are several model systems used to study 
collective migration in vivo, these include border cell migration in Drosophila embryos
43
, 
the zebrafish lateral line
44
, and the neural crest in xenopus
45
. An important aspect of the 
above model systems is the ability to observe cells in the native in vivo environment. 
Other models of directed collective migration include culturing mouse mammary 
organoids
46
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1.5  Intercellular cues regulating directed cell migration- Contact 
inhibition of locomotion (CIL) 
 
 The transition from single cell to collective cell directed migration highlights the 
importance of how cell to cell adhesion and coupling can transform single cell behavior 
to a concerted response. This suggests that in studying single cell directed migration, 
transient cell to cell interactions should not be disregarded, as they may modify and 
enhance locomotion. An important intercellular cue which influences directed cell 
migration is contact inhibition of locomotion (CIL). CIL was first observed roughly 50 
years ago by Abercrombie and Heasyman
48
, and can be defined as “the stopping of the 
continued locomotion of a cell in the direction that has produced a collision with another 
cell”
49
. Several cancer cells exhibit homotypic CIL, where collisions between two cancer 
cells will result in redirection of both cells
50
.  Conversely, when many cancer cells 
contact nonmalignant cells during heterotypic collisions, migration remains unimpeded
51
 
and can be up-regulated
52
. This suggests that CIL may mediate the dispersal of malignant 
cells away from the primary tumor by preferentially orienting protrusions, while the lack 
of CIL with other cell types may enhance the dissemination of these cells into the stromal 
environment. In this thesis we will explore the relationship between CIL and chemotaxis 






1.6  Processes in chemotaxis 
 
 In the section below, we will outline the canonical steps involved in chemotaxis, a 
form of directed cell migration, as it is a focus of this dissertation. Chemotaxis can be 
broken down into several separable steps which are essential for an accurate response. 
With the exception of adhesion, these steps are indispensable for directed migration. The 
first step involves sensing a cue which is accomplished via extracellular receptors. Next, 
cellular machinery is localized to occupied receptors which induces signaling and 
cytoskeletal polarity. Finally, cell propulsion is mediated by protrusions initiated by f-
actin polymerization or blebbing driven by actomyosin contraction. In mesenchymal cells 
such as fibroblasts, adhesion is generated at the protrusion which generates a traction 
force necessary to pull the cell body forward. In the subsections below, we will describe 
several prominent molecules involved in directed cell migration. 
 
1.6.1  Gradient sensing  
 
         Gradient sensing is achieved by receptors which uniformly decorate the cell 
membrane. In Dd and neutrophils, these receptors are G protein coupled receptors 
(GPCRs), while in fibroblasts and many cancer cells these receptors are receptor tyrosine 
kinases (RTKs). Regardless of receptor class, this uniform distribution of receptors 
allows cells to effectively sample their local environment and determine concentration 
differences across their diameter. Interestingly, various groups have demonstrated that in 
various cell types, receptor distributions remain uniform even in the presence of a 
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gradient of chemical ligands
53-55
. These experiments were carried out by introducing 
fluorescently tagged chemotactic receptors into the respective cell types and observing 
their distribution pre and post stimulation. An active cytoskeleton is not required for 
gradient sensing
56
, indicating that these processes are separable. Overall, the above 
findings suggest that intracellular molecules mediate the subsequent polarized cell 
responses. 
 
1.6.2  Polarization 
 
 Gradients of extracellular ligands induce differences in receptor occupancy across 
a given cell. These activated receptors, in turn, induce the local recruitment of several 
canonical polarity factors.  One of the chief polarity factors is phosphoinositide 3-kinase 
(PI3K) which phosphorylates phosphatidylinositol (4,5)-bisphosphate (PIP2) to create  
phosphatidylinositol (3,4,5)-triphosphate (PIP3)
42
. Directionally migrating cells have 
PIP3 confined at the leading edge, where the directionality of migration is enforced. This 







through the use of fluorescently tagged pleckstrin homology (PH) domains, which bind 





, but is not in fibroblasts
35
. Confinement of PIP3 at the 
leading edge is also mediated by the lipid phosphatase, phosphatase and tensin homolog 
(PTEN), which dephosphorylates PIP3 to PIP2. PTEN is localized to the lateral and rear 
membrane of migrating cells and is absent from the leading edge
58
. Although PI3K is a 
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crucial player in migration, cells can still undergo chemotaxis without it
12
, suggesting that 
alternative pathways are also available for directing cells
15
.  
  PIP3 localizes several pleckstrin homology (PH) domain containing proteins to 
the plasma membrane, notably, activators for small Rho GTPases known as guanine 
exchange factors (GEFs). The most well studied group of small Rho GTPases involved in 
cell migration are Rac, Cdc42, and RhoA
42
, which predominantly reside at the plasma 
membrane. These small Rho GTPases cycle between an “on” GTP bound phase and an 
“off” GDP bound phase and contain intrinsic GTPase activity. GEFs catalyze the 
exchange of GDP to GTP, thus turning “on” small Rho GTPases. Conversely, GTPase-
activating proteins (GAPS) accelerate intrinsic GTPase activity and turn “off” Rho 
GTPases. Another layer of regulation is instilled by the presence of GDP dissociation 
inhibitors (GDIs), which bind GDP bound Rho GTPases and sequester them from the 
plasma membrane.  
 Rac, Cdc42, and RhoA are central hubs in transducing upstream receptor level 
signaling to the cytoskeleton. The canonical studies from Alan Hall’s lab using 
microinjected constitutively active forms of Rac, Cdc42, and RhoA in Swiss 3T3 cells 
demonstrated that disregulation of their protein activity could produce dramatic effects on 
the cytoskeleton
59-62
. In particular, constitutively active Rac produced broad protrusions 
called lamellipodia, with a characteristic dendritic network of F-actin filaments
61
, while a 
constitutively active Cdc42 produced several spike like projections from the plasma 
membrane termed filopodia
62
. Contrary to Rac and Cdc42, constitutively active RhoA 





 Given these complex cytoskeletal phenotypes, the next logical question is where 
are the activities of these Rho GTPases localized in directionally migrating cells. This 
question was answered with the development of fluorescence resonance energy transfer 




, and a sensor for Cdc42
65
. These studies 
revealed that the activity of Rac and Cdc42 is localized to the leading edge
63, 65
, while 
RhoA activity can be observed adjacent to the leading edge and at the rear of cells
64, 66
. In 
this thesis, we will explore how the spatial distribution of active Rac controls directed 
cell migration. We will also look at the activities of Rac and RhoA in migrating MTLn3 
cells. 
 
1.6.3  Protrusion 
 
 Cell propulsion is mediated by protrusions generated off of the cell body. In some 
cases these protrusions may be produced autonomously in the absence of stimuli
67
, while 
in other cell types, they are produced in a stimulus dependent manner
68
. There are two 
main classes of protrusions, the first being f-actin mediated protrusions and other being 
actomyosin driven blebbing. F-actin mediated protrusions are driven by the force of 
polymerizing actin networks pushing against the plasma membrane. Blebbing is 
produced in an f-actin independent manner by hydrostatic pressure driven by local 
actomyosin contraction, leading to the rupture of cortical actin at the plasma membrane 
and outward movement of the membrane
69
. Recently a third class of protrusion termed 
lobodopodia was also shown to exist
25
. It is likely that these protrusive phenotypes are 
interchangeable and are variations of a general migration mode. Regardless, the diversity 
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of protrusions highlight the need to derive mechanistic insight into protrusive processes, 
as therapeutic molecule interventions may only be functional on a subset of cells. 
Activation of protrusive machinery is mediated through downstream effectors of the 
small Rho GTPases. Downstream of Rac and Cdc42 are the Wiskott-Aldrich syndrome 
protein (WASP) family proteins which can be categorized based on structure into WASPs 
and WAVEs
70
 and other effectors such as the insulin receptor substrate protein (IRSp53) 
and p21 activated kinases (PAKs). Active Cdc42 can directly interact with IRSp53 to 
mediate the formation of filopodia
71
, while active Rac can interact with WAVE 
complexes, which in turn, activate actin related proteins (Arp2/3), leading to increased 
actin branching and protrusion formation
70
.  As opposed to Cdc42 and Rac, the function 
RhoA has traditionally been associated with contraction and retraction through its 
downstream effector, Rho-associated kinase (ROCK), which functions directly upstream 
of contractile machinery such as myosin II
72
. Blebbing is thought to be driven by the 
activity of RhoA. An alternative effector of RhoA is a formin, diaphanous-related formin-
1, (mDia1), which can produce straight actin filaments leading to membrane protrusion
73
. 
These contrasting functions suggest that spatial activity of RhoA must be exquisitely 
regulated in migrating cells.  
 
1.6.4  Adhesion 
 
 The formation of a protrusion is typically followed by the establishment of local 
adhesive sites. The maturation of these adhesive sites provides a traction force for 
translocation of the cell body. A cyclic process ensures proper cell migration: adhesions 
14 
 
are formed at cell protrusions while they are disassembled at the rear of cells
74
. Adhesion 
is mediated primarily by cell surface receptors called integrins, which can bind ECM 
components such as laminin, fibronectin, and collagen
75
. Bound integrins can recruit 
several signaling species, such as focal adhesion kinase (FAK) and src family kinases 
(SFKs) as well as cytoskeletal elements
75
. Although adhesion is critical to mesenchymal 
motility, it is dispensable for amoeboid migration or migration in 3D matrices, suggesting 
that adhesion is context dependent
76
.     
 
 
1.7 Assays to study chemotaxis 
 
 Progress in the field of chemotaxis has been spurned by the development of 
assays which have allowed a mechanistic understanding of how it occurs and to which 
factors. Each assay has its own set of advantages and drawbacks. For example, assays 
which allow live cell imaging can be coupled to fluorescent biosensors, which have been 
invaluable in the phenotypic evaluation of which sets of proteins appear at the “front” and 
“back” of migrating cells. On the other hand, end point assays allow a high throughput 
analysis of what factors may induce chemotaxis. In the sections below, we describe a few 
prominent assays used to study chemotaxis. Excellent protocols on how these assays may 
be executed and evaluated can be found here
77
. We will conclude with a brief description 
of how microfluidics has been used to study chemotaxis. A more detailed look will be 




1.7.1  Micropipette assay 
 
 The micropipette assay is a straightforward method to assess chemotaxis in a 






, and cancer cells
79
. In this 
assay, a fine tip micropipette is filled with a chemoattractant of interest and is lowered by 
micromanipulators to a set distance away from a group of cells. The chemoattractant is 
then ejected from the micropipette by pneumatic pressure, which allows the control of the 
ejection volume and frequency of ejection
80
. Exponential gradients are produced from the 
tip of the micropipette and decay sharply with distance. The advantages of the 
micropipette assay are that it is relatively easy to execute, fluorescent reporters can be 
used in cells of interest, and kinetics of responses can be measured. The disadvantages of 
this assay lie in the reproducibility of the size of the tip, which may alter the shape of the 
gradient, and in throughput, as only a few cells may be imaged in a given area around the 
micropipette. Disadvantages in throughput can be magnified when studying slower 
moving cells, such as fibroblasts and cancer cells, where responses may take on the order 
of tens of minutes and gradients may need to be maintained on the timescale of hours. 
 
1.7.2  Boyden Chambers 
 
 The boyden chamber was developed by Stephen Boyden over 50 years ago as a 
simple population level assay used to assess chemotaxis
81
. The boyden chamber assay 
involves the use of a well with an upper and lower compartment separated by a porous 
membrane insert. Chemoattractants of interest are placed in the lower compartment and 
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will form a sharp gradient through the pores via diffusion. Cells seeded on the top of the 
insert will perceive the gradient and will migrate through the pores to the other side. At 
the end of the assay, cells are fixed and counted on the bottom of the insert using a 
microscope. The obvious advantage of using boyden chambers is in the high throughput 
data which can be collected, as this is an end point assay. The disadvantages of this assay 
lie in the inability to gain mechanistic insight into the chemotaxis process. For example, 
some factors may increase overall cell speed or increase cell proliferation but will not 
induce guidance. Such factors would be inaccurately assessed as chemotactic in this 
assay.  
  
1.7.3  Zigmond, Dunn, and Insall Chambers 
  
 To increase the throughput and reproducibility of chemotaxis assays, a variety of 
chambers have been developed based on diffusive gradient development between a 





, and Robert Insall
83
. In this set of assays, thin ridges are 
connected to a source and sink, thus generating a gradient across the ridges. The assay is 
initiated when a coverslip with adherent cells is inverted onto the viewing chamber, thus 
initiating a fluid connection between the source and sink. These viewing chambers allow 
the direct observation of chemotactic processes and allow the reproducible formation of 
gradients.  The disadvantages of these assays lie in the stability of their gradient profiles, 
which evolve as the sink is saturated with chemoattractant over time, in the inability to 
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observe early events of chemotaxis, and in the planar geometry of the assay which fails to 
represent the typical 3D environment in which cells reside.   
 
1.7.4  Hydrogel assays 
 
 Among the assays described above, hydrogel assays best represent the in vivo 
cellular environment. Hydrogels can be created based on native ECM molecules, such as 
collagen
47
, or with agarose
84
. In these assays, groups of cells can either be placed in a 
preformed cavity in the hydrogel or the hydrogel itself can be polymerized around them. 
A chemoattractant is placed in a nearby preformed cavity and forms a gradient by 
diffusion from the cavity into the surrounding hydrogel, thus attracting cells to migrate 
towards it. As mentioned above, the advantage of such assays is the ability to recreate in 
vivo like environments. The disadvantages of this method lie in imaging cells through the 
hydrogel, which may cause optical distortion, and in the reproducibility of the gradient, 
as cavities are manually produced.    
 
1.7.5  Microfluidic assays 
 
 Microfluidic assays allow the manipulation of fluids at the micro and nano-scale 
using custom tailored devices fabricated out of biocompatible polymers. The length scale 
of these manipulations matches the length scales of cells, thus making them well suited 
for controlling cellular microenvironments, and in particular, assaying chemotaxis. 
Mehmet Toner’s group was the first to use microfluidics to create gradients of a 
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chemoattractant to study chemotaxis in 2002
85
. They studied neutrophil responses to 
linear and complex gradients of interleukin-8 generated by an upstream “Christmas” tree 
like network. Microfluidic assays have several distinct advantages which we will outline 
in the subsequent chapter. The chief drawbacks to using microfluidics are the specialized 
setups needed to run the assays and lack of commercial availability of most devices.  
  
 
1.8. Aims and significance of this research 
 
 Progress in the field of directed migration is driven largely by the advancement of 
techniques which allow the observation of new phenomena or can ask an entirely new set 
of questions.  A prime example of this was the development of fluorescent biosensors, 
which revolutionized our understanding of how cells could sense an external gradient and 
proved a means to systematically look at the spatial and temporal behavior of 
intracellular components involved in directed migration. The general aim of this thesis is 
to explore the molecular underpinnings of directed migration through the development of 
new technologies. We seek to answer the following questions- 1) Is the graded activity of 
a core component sufficient in itself to induce directed migration? 2) How are multiple 
cues integrated during directed migration?  A specific set of aims are enumerated below. 
 
Specific Aim 1- Develop microfluidic platforms for studying directed migration 
mechanisms and phenomena in cancer cells (Chapter 2). 
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 We will begin with a review of microfluidics and will enumerate several of the 
principles of why it is an effective tool for studying cell biology. We will also provide 
several examples of how microfluidics has been used to control cell positioning and for 
the manipulation the spatial and temporal environment around cells. Finally, we will 
describe how we developed a new set of devices to study the mechanisms of directed cell 
migration in cancer cells, which will be utilized in chapters 3 and 4. Protocols for device 
fabrication are also found in this section. 
 
Specific Aim 2-  Directly recapitulate  a native, active protein distribution of a 
known regulator of cell migration in living cells and assess its affects on directed 
migration. (Chapter 3)    
 We use our first set of tools developed in aim 1 to create a platform for directly 
inducing graded activation of Rac, an important regulator of cell migration. We further 
delve into how these perturbations provide new intuition into the function of pathways 
converging on Rac activation. 
 
Specific Aim 3- Dissect how multiple cues are integrated during directed cell 
migration (Chapter 4)  
 In this aim, we use our second set of tools developed in aim 1 to understand the 
interplay between chemotaxis and CIL in controlling directed cell migration. We provide 
further insight into how this is mediated at the molecular level and the implications for 




  The research presented here makes significant contributions to the scientific 
community from both technical and mechanistic standpoints. We develop new 
technological platforms which enable sensitive control over cellular microenvironments 
and enable us to address fundamental questions in directed cell migration. We utilize 
these tools to derive new insight into the signaling mechanisms regulating directional 
migration by specifically perturbing the spatial-temporal activity of intracellular 
components. Furthermore, we present tools to study how multiple cues interact during 
directing migration in cancer cells, addressing one of the current challenges in the 
directed cell migration community. We suggest that the maturation of these tools will 












Chapter 2.  Development of microfluidic 
platforms for studying directed migration  
 
2.1  Microfluidic technologies for studying cell biology 
 
2.1.1  Introduction 
 
The term “microfluidics” denotes an extensive set of techniques and tools developed 
largely over the last decade for manipulation of fluids at the micro- and nano-liter scale 
using fabricated networks of precisely manufactured channels, chambers, and valves. 
There are several advantages to working at this small scale, including predictable fluid 
flows (only laminar flow is expected under most circumstances), small reagent 
consumption, and reduced spatial device footprints. At its inception, microfluidics was 
geared toward reducing the cost and increasing the throughput of traditional biochemical 









recent advances have expanded the breadth of microfluidics to biological applications, 
including live cell assays with real time monitoring of biochemical processes using 
diverse imaging techniques, particularly fluorescent microscopy. Microfluidic devices are 
capable of assaying multiple inputs of various magnitudes by manipulating the soluble 
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and surface immobilized cell milieu with concomitant detection of dynamic output 





These assays take advantage of a highly developed technological capacity to translate 
manipulation of liquid flows into control of the extracellular environment in a well 
defined spatial-temporal manner and the emergence of ever expanding molecular 
reporters used with highly developed microscopy systems. In what follows, we will 
Fig 2.1: Microfluidic devices are platforms allowing precise spatial and temporal 
control over inputs as well as patterning of cells and their adhesion substrates. 
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briefly introduce microfluidic devices and their beneficial properties for studying 
biological problems. We will also highlight techniques used in microfluidics devices 
falling into two general categories; positioning of cells and their adhesion substrata and 
controlling dynamically and spatially variable environments. 
 
 
2.1.2  Biocompatibility of microfluidics 
 
 
Presently, a vast majority of microfluidic devices are fabricated from 
polydimethylsiloxane (PDMS) using a process known as soft lithography. These devices 
are created via replica molding off silicon masters, where user-defined patterns deposited 
on the masters are embossed into the final device. The resulting networks of various pre-
designed features, including channels and chambers, are sealed to a surface compatible 
with imaging and, if desired, cell adhesion, such as glass, and are coupled to a flow 
input/output control system. Excellent reviews on fabrications processes can be found in 
a number of recent references
90, 91
.  Overall, the design and fabrication of PDMS devices 
can occur on the time scale of a few days, allowing rapid prototyping and general ease of 
use. 
PDMS has several advantages for use in biological assays; it is optically 
transparent, permeable to atmospheric gases, chemically inert, mechanically flexible and 
electrically insulating
92
. The optical transparency allows the use of transmitted light and 
fluorescent signals for imaging cell activity. Permeability to non-polar gases, particularly 
oxygen and carbon dioxide, is beneficial for culturing cells within devices over extended 
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periods of time. Microfluidic cell culture arrays have been developed which allow 
continuous cell culture for weeks
93
. Furthermore, electrical insulation provided by PDMS 
permits additional use of electric fields to precisely control flow and cell properties.  
In addition to the many physical and chemical benefits provided by PDMS as a 
fabrication material, there are several advantages gained from the physics of working at 
the microscopic length scale of microfluidic devices. Arguably the most important benefit 
is non-chaotic, laminar liquid flow due to a low Reynolds number, the number that 
characterizes fluid behavior in a given system. In this regime fluids mix purely by 
diffusion. For example, two parallel streams containing different molecular solutes will 
mix in a gradual manner defined by diffusion at their interface. Researchers have utilized 
this property to create concentration gradients through serial dilution of input solutions 
navigating through series of merging and splitting channels. This technique will be 
discussed in more detail below. Other benefits of working at this spatial scale include 
reduced sample volumes, opportunities for parallelization, and functional chambers at the 





2.1.3  Control of positioning of cells and their adhesion substrata 
 
 
Well established techniques exist for controlling cell positioning within 
microfluidic devices, including segregating cell populations into several discrete 
chambers, patterning multiple cell types, and isolating single cells (Fig. 2.1). Microfluidic 
devices achieve this through electrical, magnetic, mechanical and chemical cell 
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manipulation. We will describe mechanical and chemical techniques using soft 
lithography which have become standard for multiple labs. 
 
2.1.4  Patterning of cell populations  
 
 
Two of the earliest modalities for patterning populations are a) PDMS stencils to 
physically block select regions and b) using microfluidic channels to restrict the 
deposition of extracellular matrix (ECM) as the substratum for cell adhesion and to 
control cell deposition onto the substratum from cell suspensions. Folch et al. used 
PDMS stencils to restrict the attachment of primary rat hepatocytes to square zones 
across various substrates
95
, while Stine et al. used a similar system to create a co-culture 
of melanoma and human umbilical vein endothelial cells (HUVEC)
96
. Utilizing an 
alternative technique, Folch and Toner used microchannels as templates to deposit ECM 
on different biocompatible substrates
97
. After washing and removal of the elastomeric 
device, co-culture of different cell types could be achieved by adding distinct cell types 
after the initial patterning. Another method to control ECM patterning is by interfacing 
multiple laminar flow streams in microfluidic devices (Fig. 2.2a). As mentioned above, 










interface. If the flow rates are fast enough, this mixing becomes negligible over the time 
course the flows are interfaced in the device and precise boundaries between deposits 
used for patterning can be achieved. Takayama et al. used up to 5 merging microchannels 
to selectively deposit erythrocytes and E.coli in parallel lines
98
. Controlled perturbation 
of subpopulations is also possible in this configuration, as evidenced by selective 
trypsinization and labeling of bovine capillary endothelial cells
98
. On the other extreme of 
Fig 2.2: Microfluidic technologies for precise positioning of cell populations. 
 
(a) Three laminar flow streams can be used in a microfluidic device to selectively deposit 
cells in a given position. (b) A microfluidic device can be used for high throughput 
screening of cytokine responses in cell populations seeded into separate chambers. Each 
chamber can encompass an individual treatment condition and enable screening of cell 
responses. (c) Sample chambers within a microfluidic device can be used to isolate single 
E. coli cells by pressurizing surrounding valves. 
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device design complexity is the ability to use channels of simple geometric cross-sections 
(particularly triangular) for depositing smooth gradients of ECM
99
.  
Cell populations can also be distributed into separate chambers within 
microfluidic devices. When coupled to on chip valves these chambers are addressable 
individually or in groups, thus allowing screening of different inputs across large 
samples. Valves will be described in more detail below. Based on this principle, Cheong 
et al. developed a high-throughput microfluidic device to study cytokine or growth factor 
responses in cell populations across multiple concentrations and stimulation durations
100-
103
 (Fig. 2.2b). Other groups have developed similar designs
93, 104
 which have been used 
to study inflammatory processes
105
. Taylor et al. significantly expanded the throughput of 
this technology by creating a highly parallel device with 2048 assayable chambers with 
the ability to use different cell types and stimulus patterns
106
. 
Another subset of devices are designed to serve as chemostats, where cell 
populations are monitored over extended time periods with continuously renewed culture 
conditions. Balaban et al. used PDMS channels separated from a fluid network by a 
membrane to analyze the growth of single and multiple bacteria cells over time
107
. 
Medium in the fluidic channels continuously renewed nutrients via diffusion through the 
membrane to the bacteria cells underneath. Groisman et al. used a multi height single 
layer PDMS device to isolate bacteria cells in chambers adjacent to medium supplying 
channels
108
. Connections between the chambers and supply channels were approximately 
0.6 m, thinner than an E.coli cell diameter, but increasing the overall in-device pressure 
could reversibly enlarge the connections (similar to the effect of an inflating balloon), 
thus allowing cell seeding to the chambers. Continuous perfusion of media supplied 
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nutrients via diffusion from the perfusion channels through the thin connections, also 
allowing concomitant removal of waste from the chambers. Cho et al. used a similar 
device with arrays of chambers with different sizes and shapes to explore the relationship 





2.1.5  Positioning of single cells 
 
 
 Separation of autocrine from paracrine signaling is often desirable to study 
autonomous signaling at the single cell level. To remove paracrine signaling, cells need 
to be isolated individually. Single cell isolation is difficult to achieve using traditional 
laboratory techniques but a variety of microfluidic tools have been developed to address 
this issue. One of the earliest methods to isolate single cells, known as micropatterning 
utilizes PDMS as a stamp by absorbing ligands from solution and depositing them in user 
defined patterns onto substrata based the shape and area of contact with the stamp. Chen 
and colleagues used micropatterning to create different sized ‘islands’ of fibronectin to 
decouple the effects of cell spreading vs. adhesive signaling in controlling programmed 
cell death
110
. Increases in the size of islands reduced cell death but the results were 
confounded by a concomitant increase in adhesive signaling. To separate the effects, 
smaller fibronectin microspots in the 3-5 m range were created with unadhesive 
compounds between them. Cells extended across spots and a decrease in apoptosis was 
seen with increased cell spreading while having comparable integrin signaling levels, 
thus supporting a role for spreading in controlling apoptosis. 
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Geometric traps have also been successfully used to isolate single cells from 
suspension. These designs generally rely on hydrodynamic trapping, where flow is 
allowed to pass through arrays of crevices smaller than a cell diameter and are 
subsequently blocked once a cell arrives. The Lee group designed an array of U-shaped 
structures utilizing hydrodynamic trapping to isolate single cells
111
. An array of 100 cells 
was successfully captured with 85% retention after 24 hours of continuous perfusion. 
Using a similar design, the Voldman group fabricated arrays of capture cups to 
investigate cell paring and fusion
112
. Up to 70% pairing efficiencies were obtained 
between multiple cell types using a multi-step loading protocol. The device also allowed 





, and ‘docks’ at T junctions
115
.  
Another technique to isolate single cells relies on the use of elastomeric valves 
fabricated by stacking multiple layers of PDMS. This technology was pioneered by the 
Quake group and demonstrated a simple and robust method to control fluid flow
116
. A 
typical setup includes two layers of PDMS, where one layer contains the fluidic network 
and a separate valve layer is bonded on top. Channels in the top, valve layer, can be 
pressurized and subsequently deflect the PDMS membrane separating the valve from the 
fluidic network which suppresses flow. Cai et al. used on chip valves to isolate single E. 
coli in  microfluidic channels  to study protein expression using enzymatic amplification 
of secreted protein products
117
 (Fig. 2.2c). The valving technique allowed the seclusion 
of very small volumes of solution, about 100 pl, thus giving the authors the ability to 
detect single molecules.   
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Lastly, Yin et al. used dielectrophoretic (DEP) forces to induce heterotypic and 
homotypic single cell paired interactions in a microfluidic device
118
. Generation of 
polarized electric fields across cells in a device can lead to electrical polarization of the 
cells themselves. This polarization is sufficient to pull cells towards sources of maximum 
or minimum DEP depending upon intrinsic cell properties and the surrounding medium. 
The researchers were able to precisely pair together different cell types, a549 human lung 
cancer cells with human umbilical vein cells (HUVEC), or cells of the same cell types.    
 




Beyond patterning of cell positions, microfluidic devices have the capability of 
controlling cell stimuli in space, magnitude and time (Fig. 2.1). Possible perturbations of 
the cell microenvironment include a) generation of spatial gradients of input signals 
through progressive serial dilution of two or more input streams into a series of streams 
spanning several orders of magnitude in concentration; b) diffusion based gradient 
formation, and c) creation of complex, temporally variable stimuli defined over a variety 
of time scales, including oscillatory inputs. These complex input distributions are made 
possible through the predictable mixing behavior of fluids in microfluidic channels. They 
have been utilized to study fundamental cellular behaviors, such as chemotaxis, axon 
guidance, inflammatory responses, differentiation, as well as activation of mutiple 
signaling pathways. Below we provide several illustrative examples of how microfluidic 
generation of diverse spatial and temporal stimuli can be used to address important 









 Valves in microfluidic devices, whether external or internal, have enabled the 
creation of dynamically changing input signals, as complex as e.g., pulsatile or ramp 
stimuli, which can be adjusted in frequency, amplitude, and shape
119
. As opposed to the 
step inputs, typically applied by addition of a stimulus to a dish, oscillatory stimuli can 
reduce noise, reveal the bandwidth of a pathway, and help understand adaptation 
mechanisms
120, 121
. Microfluidic devices designed to produce waveforms typically have 
multiple input streams gated by valves. Actuation of valves controls which stream enters 
the cell microenvironment, thus allowing the formation of square waves by rapidly 
switching between streams of different concentrations (Fig. 2.3a). More complex 
waveforms can be achieved by allowing the input streams to mix in different proportions 
by controlling their relative flow rates.  
In one of the first studies to utilize microfluidic generated waveforms, Mettetal et 
al. used a valve driven flow system to generate square waves of different osmolyte 
concentrations to study the osmo-adaptation pathway in yeast
122
. A biosensor for high-
osmolarity glycerol (HOG) was used to quantify signaling responses to the induced 
stresses. The effects of two previously known negative feedbacks in the HOG pathway, 
through fast and slow mechanisms, were decoupled by comparing the frequency 
responses of wild type yeast with a mutant harboring decreased HOG1 activity. Similarly, 











Fig 2.3: Microfluidic technologies for controlling cellular environments. 
 
(a) Schematic of a simple microfluidic device used to generate square waves of input by 
switching between two input solutions containing different concentrations of inputs. (b) A 
microfluidic gradient generating network with three inputs. When solutions containing 
different concentrations of fluorescein are connected to the different inlets, various 
gradient profiles can be obtained. (c) A microfluidic device used to generate gradients 
across test chambers of various sizes by diffusion. Two flow-through channels are 
connected by the test chambers. Stimulants are introduced into one flow-through channel 
and form a linear gradient across the test channels by diffusing towards the other flow-
through channel. (d) A three inlet microfluidic device, similar to that shown in Fig. 2.2a 
is used to selectively stimulate a portion of a cell seeded into the chamber. 
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of the inputs and thus their interface across a channel, to investigate the bandwidth of the 
HOG pathway
123
.  Microfluidic waveform devices have also been used to study 
metabolic regulation
124





2.1.8  Spatial control of inputs 
 
 
The methodology of generating soluble and surface bound gradients of 
biologically active molecules was first demonstrated by the Whitesides group
125, 126
 (Fig. 
2.3b). Analogies between electric and fluidic circuits were used to predict the serial 
dilution of input streams via multiple junctions, splitters, and fluidic resistors. The 
resulting output streams, spanning the concentration range defined by the input 
concentrations, can be merged in an outlet channel to generate the final concentration 
gradient. One of the first studies utilizing microfluidic gradient generation was carried 
out by Jeon et al. to study the chemotaxis of neutrophils in gradients of a chemokine, 
interleukin-8
127
. Gradients in this analysis could be generated within seconds and 
maintained stably pending available reagents. This device allowed concurrent time-lapse 
imaging of initial neutrophil responses as well as quantitative characterization of motility 
vs. several applied gradients. Complex gradient shapes could be created in addition to 
linear gradients, including parabolic and “sawtooth” shaped gradients profiles. Others 
have applied similar designs to create exponential gradients
128
, fast switching 
gradients
129
, multiple opposing gradients
130





Gradient generating networks can be slightly adjusted to create several discrete 
dosages rather than a smooth gradient. Instead of merging separate streams of different 
concentrations, the streams can be fed into separate channels, thus exposing each channel 
to a well predicted, discrete concentration spanning the range of the inputs. Thompson et 
al. utilized such a device with an upstream dilution module and downstream cell 
chambers to look at the dynamics of NF-B activity in cells across multiple densities and 
concentrations of TNF-
132
. The advantage of such parallel exposure designs is the rich 
variety of data obtained in a single experiment with the simple preparation of two input 
solutions. We will utilize a similar design to study the EGF dose dependence of CIL in 
MTLn3 cells in chapter 4. 
The techniques discussed above can be lumped together as flow-based techniques, 
in which continuous flow is needed to maintain the gradient. For non-adhesive or less 
robust cell types, milder gradient generating techniques have been developed which rely 
on passive solute diffusion between a source and sink.  A source and sink can be linked 
together by one or more channels and a linear gradient can be generated between these 
channels via diffusion. If the source and sink are continuously renewed due to liquid 
perfusion, the established gradient can persist indefinitely. Modulation of the steepness of 
gradients can be achieved by varying channel lengths, while variation of widths can 
modulate cell numbers. Paliwal et al. developed and used a microfluidic device based on 
this principle to study the mating response of yeast in gradients of pheromone
133
 (Fig. 
2.3c). A variety of mating phenotypes could be observed at different concentrations of 
pheromone, with cells also displaying different chemo-sensing accuracies. Similar 







devices utilized in chapter 3 and 4 are based on the principles of passive gradient 
generation. 
 Sub-cellular patterning of stimuli is also achievable through microfluidics. The 
well-defined interface between multiple streams in a microfluidic device can be 
positioned over single cells to induce spatially heterogeneous stimulation. Takayama et 
al. used a microfluidic device to label select populations of mitochondria within a single 
cell and also induced local disruption of actin filaments
137
 (Fig. 2.3d). Similarly, Sawano 
et al. locally exposed Cos-7 cells to epidermal growth factor (EGF) to determine the 
extent of lateral propagation of downstream signaling
138
. Interestingly, the lateral 
propagation increased with overexpression of EGF receptors, thus elucidating a new 
mechanism enabled by microfluidic technology. 
 
2.2  Development of a microfluidic platform for inducing subcellular 
gradients 
  
 In this subsection, we will outline the development and rationale behind the 
microfluidic device used in chapter 3. We will enumerate a set of device requirements we 
satisfied in order to achieve a functioning device. We will follow this with a discussion 
on how our design met those requirements. Finally, we will provide a protocol of how we 
produced our devices. 
 




 The primary requirements of our device were as follows- 1) generate gradients of 
a soluble chemical in a reproducible fashion, 2) generate these gradients across single 
cancer cells, and 3) do this in a high throughput manner. We also had two other 
secondary criteria. The first was to minimize shear stress across cells. Shear stress has 
been shown to induce directed migration responses, alter cell signaling, and reduce cell 
viability
139
, and thus could obfuscate responses to soluble chemicals. The second was to 
have all cells receive the stimulus at a time scale which would be negligible compared to 
the time scale of cell responses. For example, if cell responses occurred on the order of 
tens of minutes, then a time window of a few minutes would be reasonable for all cells to 
receive the stimulus. This would, in turn, allow us to accurately assess the cell response 
kinetics across the population.   
 
2.2.2  Device design 
 
 Our design (Fig 3.1, Fig. 3.2) was inspired by studies carried out by our lab to 
study gradient sensing in yeast
133
 and by the Toner group for studying neutrophil 
chemotaxis
140
. Gradient generation is achieved by diffusion between a source and sink, 
similar to the principles of the various chambers described in the introduction
23, 82, 83
. 
However, in our device, the source and sink are continually replenished by flow 
originating from an upstream network, thus maintaining a very reproducible gradient at 
steady state indefinitely, as long as the volumes of the respective sources are maintained. 
This fulfilled one of our primary requirements of having a well controlled gradient. We 
connected our source and sink by 250 individual microchannels with widths (18 m) 
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matching the diameters of single HeLa cells. This gave us 250 potential opportunities to 
assay single cells, thus allowing us to have high throughput yield of single cell data and 
fulfilling our two other primary requirements. To reduce the potential shear stresses in 
our system, we introduced two modifications. First, we optimized the ratio of the height 
of the microchannels to those of adjacent source and sink to minimize cross flow between 
them. The resistance in a given rectangular channel with a high aspect ratio can be 
approximated with the following equation- 
 
  
    
   
 
where R = resistance, the viscosity of the fluid, L = the channel length, w = the 
channel width, and h = the channel height
94
.  As the height term dominates the resistance 
equation, we found an optimal ratio to be ~1:16 with the height of the microchannels 
being 6 m and the source and sink having a height of 100 m, thus providing a ~25 fold 
increase in resistance and drop in flow rate in the microchannels. Second, we used the 
flow balancing scheme from the Toner group
140
, where the source and sink input streams 
meet and split off before entering the main interrogation chamber. This provides an 
opportunity for any flow imbalances in the input streams to balance out. Thus with these 
two modifications we fulfilled the first of our two secondary criteria in minimizing shear 
stress across cells. Finally, we found that the response kinetics in our experiments 
(Chapter 3) were on the order of tens of minutes. We optimized the flow rate in our 
devices to have all cells experience the gradient in less than 5 minutes, therefore fulfilling 




2.2.3 Device fabrication protocol 
 
 We provide a general protocol here for fabricating microfluidic devices used in 
chapter 3. This protocol necessitates the use of a clean room, as dust or other air 
pollutants can cause significant defects. We create our device designs in Freehand 
(Macromedia); however, any computer assisted design (CAD) software can be used to 
create devices. These designs can then be printed on a high resolution mylar transparency 
from a printing company. For low resolution designs (smallest feature > 20 m), we 
recommend In Tandem design (Towson, MD), while for high resolution designs, we 
recommend CAD art services (Bandon, Oregon).  Care must be taken to ensure the 
resolution is high enough to match the smallest feature size.   
 
Microchannel layer 
1) Clean a 3 inch Silicon wafer using spray bottles positioned over an appropriate waste 
container in the following order- 1) Acetone, 2) Isopropanol, and 3) DI water. 
2)  Dry wafers using nitrogen air stream and place on hotplate >100 
◦
C for at least 5 
minutes to ensure all water has evaporated. 
3) Spincoat SU-8 3005 (Microchem) at 3000 rpm for 30 seconds. 
4) Soft bake the wafer on a hotplate at 95
◦
C for at least 10 minutes. 
5) Expose the wafer using a mask aligner using a constant energy of 1000 mJ/cm^2.  
 (We utilize a long pass UV quartz filter (Omega Filters) which provides straighter 
channels but require more exposure energy.)  
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6) Post exposure bake for 1 hour at 95
◦
C. 
7) Develop in SU-8 developer (Microchem). 
8) Hard bake for at least 1 hour at 200
◦
C. 
   
 
Fluidic layer 
1)  Use the microchannel layer wafer created above and repeat steps 1 and 2 above. 
2)  Spincoat SPR-220-7 (Megposit) at 730 rpm for 30 second on the silicon wafer. 
 (note- silane coating may improve the adhesion of  SPR-220-7) 
3) Soft bake for 8 minutes at 115
◦
C. 
4) Allow the SPR-220-7 coated wafer to rehydrate at room temperature for at least 1 
hour. Care must be taken to align the fluidic layer to alignment marks put into the 
microchannel layer. 
5) Expose the wafer using a mask aligner using a constant energy of 600 mJ/cm^2. 
6) Develop using a 1:4 dilution of AZ400K developer (Clariant). 
7) Round channels by baking at 125
◦
C for 15 minutes. 
 
 
Control valve layer 
1) Use a new silicon wafer and follow steps 1 and 2 as outlined for the microchannel 
layer. 
2) Spincoat SU-8 2025 at 1500 rpm for 1 minute. 
3) Soft bake the wafer at 95
◦
C for 2 hours. 
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4) Expose the wafer using a mask aligner using a constant energy of 2000 mJ/cm^2. 
5) Post exposure bake for 1 hour at 95
◦
C. 
7) Develop in SU-8 developer (Microchem). 




PDMS device fabrication 
1) Prepare a 8:1 and 20:1 mixture of component A to component B of RTV615 
(Momentive) and mix in weight boats for at least 5 minutes. 
2)  Remove air bubbles with a vacuum chamber. 
3) Treat the microchannel + fluidic layer wafer and the control layer wafer with 
chlorotrimethylsilane (TMCS) by placing wafers into a vacuum dessicator and placing a 
few drops of TMCS into a bottle cap. Evacuate the chamber and let sit for at least 20 
minutes. 
4)  Spincoat the 20:1 mixture onto the microchannel + fluidic layer wafer at 1600 rpm for 
60 seconds.  
5) Place the control layer wafer into a heat resistant container and pour the 8:1 mixture on 
top.  
6) Place the spincoated microchannel + fluidic layer wafer and the coated control wafer 
into an oven for 30 minutes at 85
◦
C. 
7) Carefully remove peel the solidified PDMS off of the control wafer. 
8) Cut out individual devices using a razor blade and punch inlets. 
9) Align devices onto spincoated microchannel + fluidic layer wafers and place in the 





10) Cut out completed devices using a razor blade by tracing the boundaries.  
11) Punch inlets of the fluidic layer. 
12) Carefully remove the PDMS layer between the fluidic layer and the control layer by 




1) Clean devices with an alconox solution and rinse thoroughly with DI water.  
2) Rinse with 70% Ethanol and dry using a filtered air stream. 
3) Clean a 22 x 40 mm glass coverslip (Fisher) using 70% Ethanol and dry using a 
filtered air stream. 
4) Place cleaned device on glass coverslip and make sure no air bubbles are present. 
5) Place the device in an oven set at 85
◦
C overnight to induce a strong, reversible bond. 
 
 
2.3  Development of a microfluidic device for studying directed 
migration phenomena in cancer cells  
 
 In this subsection, we will outline the development and rationale behind the 
microfluidic device used in chapter 4 (Fig 4.1, Fig. 4.2). We will again enumerate a set of 
device requirements we satisfied in order to achieve a functioning device. We will end 




2.3.1 Device requirements 
 
 Many of the primary requirements of this device were similar to those described 
for the device used in section 2.2. These requirements were generating reproducible 
gradients of soluble chemicals across cancer cells in a high throughput manner. The 
secondary requirement of low shear stress across cells also applied. However, matching 
the time scales of cell responses in this assay presented new challenges. The goal of this 
device was to study the mechanisms of chemotaxis in MTLn3 cells to gradients of EGF. 
The response kinetics of MTLn3 cells to EGF is on the order seconds to minutes
54
, an 
order of magnitude faster than the response kinetics of HeLa cells to rapamycin seen in 
the previous device
141
. Therefore, a similar gradient introduction scheme would not work 
in this system, as early cell responses could be missed across the cell population.  We will 




2.3.2  Device design    
 
 
 To ensure that all cells received the stimulus at the same time scale, we 
introduced top down elastomeric valves between the microchannels and the source and 
sink (Fig 4.2). These valves allowed us to functionally isolate the microchannels while 
pre-establishing the source and sink. Once the source and sink were at steady state, 
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opening the valves enabled the simultaneous formation of the gradient by diffusive flux 
across all channels. Thus, all cells receive the stimulant at the same time which enables 
an accurate comparison of the response kinetics. 
 We also modified the upstream flow balancing scheme to reduce the potential 
contamination of the sink by the source stream due to upstream diffusion. We placed a 
shunt at the junction of the source and sink which connects directly to the outlet (Fig 4.2). 
By carefully optimizing fluidic resistances in our design, any pressure imbalances 
between the source and sink input streams are transmitted to the shunt and do not 
influence downstream gradient. Moreover, any contamination between the source and 
sink streams is transported through the shunt and is not propagated downstream.  
 
 
2.3.3 Device fabrication protocol 
 
 The device fabrication protocol of this device is quite similar to that in section 
2.2.3, however, we made several modifications to incorporate valves between the 




1) Clean a 3 inch Silicon wafer using spray bottles positioned over an appropriate waste 
container in the following order- 1) Acetone, 2) Isopropanol, and 3) DI water. 
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2)  Dry wafers using nitrogen air stream and place on hotplate >100 
◦
C for at least 5 
minutes to ensure all water has evaporated. 
3) Spincoat SU-8 3005 (Microchem) at 3000 rpm for 30 seconds. 
4) Soft bake the wafer on a hotplate at 95
◦
C for at least 10 minutes. 
5) Expose the wafer using a mask aligner using a constant energy of 1000 mJ/cm^2.  
 (We utilize a long pass UV quartz filter (Omega Filters) which provides straighter 
channels but require more exposure energy.)  
6) Post exposure bake for 1 hour at 95
◦
C. 
7) Develop in SU-8 developer (Microchem). 
8) Hard bake for at least 1 hour at 200
◦
C. 
   
 
Fluidic layer 
1)  Use the microchannel layer wafer created above and repeat steps 1 and 2 above. 
2)  Spincoat SPR-220-7 (Megposit) at 730 rpm for 30 second on the silicon wafer. 
 (note- silane coating may improve the adhesion of  SPR-220-7) 
3) Soft bake for 8 minutes at 115
◦
C. 
4) Allow the SPR-220-7 coated wafer to rehydrate at room temperature for at least 1 
hour.  
5) Expose the wafer using a mask aligner using a constant energy of 600 mJ/cm^2. Care 
must be taken to align the fluidic layer to alignment marks put into the microchannel 
layer. 
6) Develop using a 1:4 dilution of AZ400K developer (Clariant). 
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7) Round and hard bake channels by baking at 200
◦





Source and Sink layer 
1) Use the microchannel + fluidic layer wafer created above and repeat steps 1 and 2 
from the microchannel layer protocol for cleaning. 
3) Spincoat SU-8 3050 (Microchem) at 1000 rpm for 30 seconds. 
4) Soft bake the wafer on a hotplate at 95
◦
C for 2 hours. 
5) Expose the wafer using a mask aligner using a constant energy of 3000 mJ/cm^2. Be 
sure to align the source and sink layer with the previous two layers using a third set of 
alignment marks. 
 (We utilize a long pass UV quartz filter (Omega Filters) which provides straighter 
channels but require more exposure energy.)  
6) Post exposure bake for 1 hour at 95
◦
C. 
7) Develop in SU-8 developer (Microchem). 




PDMS device fabrication 
1) Prepare a 8:1 and 20:1 mixture of component A to component B of RTV615 
(Momentive) and mix in weight boats for at least 5 minutes. 
2)  Remove air bubbles with a vacuum chamber. 
3) Treat the microchannel + fluidic layer wafer and the control layer wafer with 
chlorotrimethylsilane (TMCS) by placing wafers into a vacuum dessicator and placing a 
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few drops of TMCS into a bottle cap. Evacuate the chamber and let sit for at least 20 
minutes. 
4)  Spincoat the 20:1 mixture onto the microchannel + fluidic layer wafer at 390 rpm for 
60 seconds.  
5) Place the control layer wafer into a heat resistant container and pour the 8:1 mixture on 
top.  
6) Place the spincoated microchannel + fluidic layer wafer and the coated control wafer 
into an oven for 30 minutes at 85
◦
C. 
7) Carefully remove peel the solidified PDMS off of the control wafer. 
8) Cut out individual devices using a razor blade and punch inlets. 
9) Align devices onto spincoated microchannel + fluidic + source and sink layer wafer 
and place in the oven for at least 1.5 hours at 85
◦
C. 
10) Cut out completed devices using a razor blade by tracing the boundaries.  




1) Clean devices with an alconox solution and rinse thoroughly with DI water.  
2) Rinse with 70% Ethanol and dry using a filtered air stream. 
3) Clean a 22 x 40 mm glass coverslip (Fisher) using 70% Ethanol and dry using a 
filtered air stream. 
4) Place cleaned device on glass coverslip and make sure no air bubbles are present. 
5) Place the device in an oven set at 85
◦




2.4  Discussion 
 
 The microfluidic devices described in section 2.2 and 2.3 (Illustrated in Fig 3.2 
and Fig 4.2, respectively) will be utilized in Chapters 3 and 4, respectively. These 
microfluidic device designs enable the investigation of a new set of questions in the 
mechanisms of directed migration by allowing sensitive control of cellular 
microenvironments. We suggest that they will be applicable to a variety of cell types and 


















Chapter 3. Synthetic spatially graded Rac 
activation drives cell polarization and movement 
 
 
3.1  Introduction 
 
 
 Directional motility is an intrinsic ability of many eukaryotic cells to migrate to 
predetermined locations in an efficient manner. Migration bias is tuned by the detection 
of various guidance cues that often form spatial gradients. The extracellular gradients of 
diffusing or surface bound ligands can lead to spatially graded occupancy of extracellular 
receptor
10
. The spatial asymmetry in receptor occupancy is subsequently translated into 
an intracellular gradient of polarity effectors which can modify cytoskeleton and lead to 
the development of an asymmetric cell morphology with functionally distinct front and 
rear ‘compartments’. Remarkably, many cell types can accurately detect less than a 5% 
difference between ligand concentration at the cell front and back
10, 23, 142
. This exquisite 
sensitivity suggests that intracellular amplification of extracellular cues may be 
necessary. Indeed, various groups have demonstrated the existence of local positive 
feedback loops
143-146 
as well as mutual inhibition between different regulators
147, 148
 as 
likely candidates for response amplification.  However, recent studies have also shown 
that directional motility can still be achieved, albeit less efficiently, when once thought 
indispensable molecules involved in putative amplification mechanisms are removed
12, 13
. 
Thus the various functions of signaling components associated with directed migration 




 An attractive method for resolving the roles of signaling network components in 
both spatial cue sensing and directed cell motility is direct activation of these components 
in a spatially constrained and rapid manner, independent from initiation of upstream, 
receptor-level signaling. Utilizing this principle, a variety of studies have used optical 







as key components which are sufficient to direct cellular motility. However, an 
important caveat to these studies has been the reliance upon highly localized activation 
that can create artificial regional amplification of  target protein activity. In contrast, in 
more physiological settings, a cell processes a shallow gradient of an external cue into a 
graded intracellular response, as reflected in polarized effectors
11
, including those of the 
small Rho GTPase family
63-65
. Thus it remains unclear if an induced shallow gradient of 
an active motility signaling component is capable of reconstituting cell polarization and 
motility. In particular, it is unknown if such perturbations are sufficient to override or 
enhance endogenous intracellular signaling of the same component.  Finally, localized 
activation of signaling processes presents considerable challenges to quantitative analysis 
and coupling to detailed computational models developed to describe more natural, 
spatially distributed signaling events.  
 
 To address these questions, we created microfluidic devices permitting generation 
of precise gradients of extracellular cues
133
 and interfaced them with a rapamycin induced 
dimerization system
157
. In this system, the addition of rapamycin leads to dimerization of 
two intracellularly transduced molecular components, FK506 binding protein (FKBP) 
50 
 
and the rapamycin binding domain of FKBP-rapamycin-binding protein (FRB)
158
. 
Localization and signaling motifs can be linked to either domain, allowing spatial-
temporal control of protein function. We used our combined system to study the effects 
of a rapidly induced intracellular gradient of activated Rac, an important regulator of cell 
polarity
59




3.2  Results 
 
3.2.1  System design 
 
 To directly activate endogenous Rac, we introduced two constructs into HeLa 
cells, a cytoplasm localized effector unit consisting of YFP tagged TIAM1, a Rac GEF, 
conjugated to FKBP (YF-TIAM1) and an anchor unit at the cell membrane, Lyn11-FRB 
(LDR). The introduction of rapamycin dimerizes these modified molecular components, 
thereby bringing TIAM1 in close proximity to the cell membrane where it activates 
endogenous Rac
157
 (Fig. 3.1a). Due to the chemical nature of the activation, this system 
is amenable to generation of a gradient of Rac activity through microfluidic production of 
rapamycin gradients.  Microfluidic tools have recently been used for the control of 
complex gradients of extracellular cues
85, 128, 133
,  cellular localizations
159, 160
 and shaping 
cell morphologies
140, 161



















Fig 3.1: Graded activation of Rac directs cellular polarity. 
 
 (a) A schematic of the mechanism of Rac activation by rapamycin induced 
heterodimerization.  (b) The microfluidic device used to generate linear gradients of 
rapamycin with a sample image of the microchannels seeded with individual HeLa cells 
and the corresponding gradient visualized with Alexa 594 dye. Ports are labeled 
according to function. The red layer of the device is the fluid flow layer, while the green 
layer is the control valve layer. Alexa 594 dye is used to visualize the gradient (red) in all 
subsequent images. A sample image of a cell transfected with the Rac activator, YF-
TIAM1 experiencing a gradient of rapamycin is shown below. (c-f)  Four polarity states 
observed after the attachment period with respect to the direction of the imposed 
rapamycin gradient and associated polarization responses to the gradient of rapamycin. 
Images are rotated by 90
◦
 to aid in visualization. Cartoons illustrate the polarity of the 
associated state and the direction of the gradient. The green color indicates expression of 
YF-TIAM1. Yellow arrows denote the initial direction of polarity. The rapamycin 
gradient is shown in the 5 minute image and removed in subsequent images for clarity. 
Red dotted lines highlight evolving changes in cell morphology. Times are in minutes. 
Scale bars, 10 m. (g-j) Kymographs taken across cell centers (specified in 
accompanying image) illustrating the morphological changes of the corresponding cells in 
c-f over the experimental period. Blue lines trace initially polarized faces while red lines 
trace initially unpolarized faces. Yellow arrows denote the initial response time and their 
location indicate which cell face was the first to change in the gradient. White arrows 




We applied a previously developed strategy for imposing diffusion based linear gradients 
onto cells housed within narrow channels
133, 140
. Specifically, the devices contained a 
series of 6 m tall microchannels for cell experimentation, flanked by 130 m tall main 
flow-through channels (Fig. 3.2a). Actuation of flow led to the development of a linear 
gradient across the shallow channels due to uneven stimulus concentration in the flow-
through channels (Fig. 3.1b).  The microchannels were designed to be on the order of a 
cell diameter to relegate cells to a uniaxial phenotype (Fig. 3.1b). HeLa cells introduced 
into the microchannels settled into random locations and after a 3-4 hour attachment 
period were categorized into different polarity states according to the existence of a 
lamellipodium (State I- no lamellipodium) and its direction (State II- lamellopodium 
towards the high side of the gradient, State III- lamellipodium towards the low side of the 
gradient, State IV- lamellopodia towards both sides)   (Fig. 3.1c-f). The overall 
distribution of phenotypes was skewed towards cells with single leading edge 
lamellipodium, indicating an intrinsic preference for directed motility (Fig. 3.2b).  
 
3.2.2  Direct generation of active Rac gradients 
 
 To evaluate HeLa cell responses to synthetic generation of an intracellular 
gradient of active Rac, we exposed cells to a linear gradient of rapamycin (0 - 2 nM 
across the channel or 0.01 nM/m; yielding front/back concentration differences ranging 
from ~15-92% across varied cell lengths) visualized by Alexa 594, a fluorescent dye with 
a similar molecular weight (Fig. 3.1b and Fig. 3.2c). We chose this concentration range 
to avoid saturating the FKBP-FRB system with rapamycin (KD = 12 nM
162















Fig 3.2: Characterization of the microfluidic device and motility controls. 
 
(a) The schematic of the microfluidic device used in experiments. The layer labeled in 
blue is the control layer containing fluidically actuated valves used to control the separate 
fluidic layer below, labeled in red. The green layer indicates the region where the 
microchannels are housed and where cells are seeded. (b) Quantification of the fractions 
of HeLa cell polarity phenotypes observed after a four hour attachment period. Data are 
presented as the mean from n = 8 experiments, with error bars representing the standard 
error of the mean (SEM). (c) Quantification of the gradients of Alexa 594 dye in the 
microchannels generated to visualize the distribution of rapamycin, with colored lines 
quantifying fluorescence intensity to demonstrate the linearity of the gradient profiles and 
consistency of the gradients in multiple adjacent channels. (d) Images of HeLa cells on 
fibronectin coated glass before and after the addition of indicated chemicals. Times are in 
minutes. Scales bars, 50 µm. (e) Average velocities of HeLa cells in various treatment 
conditions. There is no significant difference between conditions. Number of samples are 
indicated. (f-g)  Representative examples of untransfected HeLa cells experiencing a 
gradient of the dye as in (c), with added rapamycin (e) and without added rapamycin (f). 
The cells show limited morphological changes through a four hour period. Time values 
are in minutes. Scale bars, 10 µm. 
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consequence of using these concentration values was a slow-down of the response times 
as compared to  previously reported values for saturating uniform rapamycin inputs
157
. 
However, the slower response times allowed a better resolution of the effects of gradually 
accumulating Rac activity and were far below those reported to affect the function of the 
mammalian target of rapamycin (mTOR)
163
. As a control, we compared basal cell 
motility with and without rapamycin and found that the addition of rapamycin had 
negligible effects (Fig. 3.2d-e). We tracked both the initial state and subsequent cell 
responses by imaging over a four hour time period. 
 
  Strikingly, we found that the shallow linear gradient of rapamycin could trigger 
and direct motility of cells in all initial polarity states in the direction up the gradient 
(Fig. 3.1c-f). Unpolarized (state I) and bipolar cells (state IV) demonstrated symmetry 
breaking with either the establishment of a leading edge or the enhancement of one 
lamellipodium and retraction of the other, respectively (Fig. 3.1c, f). Cells already 
polarized in the direction of the gradient (state II), exhibited widening and extension of 
the leading lamellipodium and movement up the gradient (Fig. 3.1d). Interestingly, cells 
initially oriented in the direction opposite of the gradient (state III) repolarized (Fig. 
3.1e). In all states, the initiation of migration was followed by a pronounced enhancement 
of cell polarity (Fig. 3.1g-j).  The directed cell polarization and migration responses were 
not observed in untransfected cells (Fig. 3.2f), or if the rapamycin gradient was not 
imposed (Fig. 3.2g). For validation of our system, we applied linear gradients of 
rapamycin to similarly transfected MTLn3 cells, a rat mammary adenocarcinoma line 
used to assay chemotaxis to epidermal growth factor (EGF) in vitro
79





3.3). MTLn3 cells exhibited initial polarity states similar to those seen in Hela cells and 
polarized towards gradients of rapamycin (Fig. 3.3). Our data suggests that our system is 
applicable across multiple cell types and can be used to study signaling pathways 









 To verify that the externally imposed rapamycin gradient was translating into a 
graded change in active Rac across cells, we carried out two control experiments. First, 
we sought to confirm that the Rac activator, YF-TIAM1, translocated to the membrane in 
a graded fashion over time. Our results above indicated that translocation of YF-TIAM1 
results in the formation of ruffling and substantial changes in cell morphology which 
Fig 3.3: MTLn3 cell responses to rapamycin gradients. 
 
(a-d) MTLn3 cells in various initial polarity states, similar to those seen in HeLa 
cells, become polarized towards gradients of rapamycin. The green color indicates 
expression of YF-TIAM1, while the red color indicates the rapamycin gradient. 
Yellow arrows indicate initial protrusions. Times are in minutes. Scale bars, 10 m. 
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obscure translocation, therefore we used an YFP tagged FKBP (YF) without TIAM1 to 
assess translocation. YF was previously shown to translocate with similar kinetics to YF-
TIAM1
165
 and therefore could serve as a suitable proxy. We tracked the membrane to 
cytoplasm ratio of fluorescence intensities across the length of cells in a gradient of 
rapamycin over time and found that membrane translocation of YF was increasing in a 
graded manner, with higher translocation towards the high side of the gradient (Fig. 3.4a-
f). We did not observe a similar response when DMSO was substituted for rapamycin 
(Fig. 3.4g-h). In both conditions we did not observe any significant morphological 
changes, indicating that translocation of FKBP constructs without effectors does not 
perturb morphology. Having verified that the rapamycin gradient induced graded 
membrane translocation of FKBP constructs, we used a Raichu Rac FRET sensor
166
 to 
monitor the resulting changes in Rac activity. In these experiments, we used an mCherry 
tagged FKBP-TIAM1 (MCHF-TIAM1) to activate Rac.  At a basal level before 
stimulation, state I cells did not show polarized Rac activity (Fig. 3.5a) while state II and 
state III cells exhibited higher levels of Rac at lamellipodia (Fig. 3.5b,c). Upon 
introduction of the rapamycin gradient, we observed increases in Rac activity in the 
direction of the gradient in all cells, while state III cells exhibited an additional decrease 
in Rac activity in the original lamellipodium (Fig. 3.5a-c). We quantified the average Rac 
activity across cells over time and found that there was a gradual and spatially graded 
increase in Rac activity in all cell states (Fig. 3.5d-f). State III cells in particular exhibited 
a sharp increase in Rac activity in the newly formed protrusion and decrease in the initial 
opposite facing protrusion (Fig. 3.5f).  As a control, we quantified Rac activity across 














Rac FRET sensor. Under these conditions, we did not observe any significant changes in 
Rac activity over time in gradients of rapamycin (Fig. 3.5g,h). Overall our results  




(a-c) HeLa cells in states I-III transfected with YFP-FKBP exposed to a gradient of 
rapamycin from top to bottom. Time 0 is chosen as 30 minutes before translocation. Cell 
length plot indicates axis of quantification in plots (d-f). Yellow arrows indicate initial 
protrusions. Times are in minutes. Scale bars, 10 m. (d-f) Quantification of the average 
membrane to cytoplasm intensity ratio across state I-III cells over time. Ratios after time 0 
are normalized to the membrane to cytoplasm fluorescence intensity ratio at time = 0 
(shown in black). Thinner colored lines indicate S.E.M of corresponding ratio profiles. 
Numbers of samples are indicted. (g) Control cells exposed to a gradient of DMSO instead 
of rapamycin do not show translocation. Cell length plot indicates axis of quantification in 
(h). Times are in minutes. Scales bars, 10 m. (h) Quantification of the membrane to 
cytoplasm intensity ratio across control cells over time. The ratio fluctuates around the 












Fig. 3.5: Quantification of graded Rac activity  
 
 
(a-c) HeLa cells in state I-III transfected with a Raichu-Rac FRET probe and an mCherry 
tagged FKBP-TIAM1 (MCHF-TIAM1) experiencing a gradient of rapamycin from top to 
bottom over time. Time 0 is chosen as 30 minutes before morphological changes in 
MCHF-TIAM1 images. Cell length plot indicates axis of quantification in plots (d-f). 
Yellow arrows indicate initial protrusions. Times are in minutes. Scales bars, 10 m. (d-f) 
Quantification of average FRET activity across state I-III cells over time in gradients of 
rapamycin. FRET profiles after time 0 are normalized to the initial profile at time 0 (shown 
in black). Thinner colored lines indicate S.E.M of corresponding average profile. Numbers 
of samples are indicated. (g) Control cells that do not express the Rac activator (MCHF-
TIAM1) exposed to gradients of rapamycin. Only slight fluctations in Rac activity were 
detected. Cell length plot indicates axis of quantification in (h). Times are in minutes. 
Scale bars, 10 m. (h) Quantification of the average FRET profile across control cells over 




suggested that an exogenously applied linear gradient of rapamycin could result in a 
graded increase in Rac activity which was sufficient to direct motility and polarization of 
cells from a variety of pre-existing polarity phenotypes.   
 For further validation of our system, we compared cellular responses to graded 
rapamycin with responses to uniform rapamycin stimulation.  Cells given a uniform 
stimulus for the entire experimental period displayed extensive uniform flattening with 
little net motility (Fig. 3.6a). This result was in agreement with previous experiments 
showing that differentiated HL-60 cells exposed to spatially uniform stimulation of Rac 
displayed membrane ruffling around the entire cell periphery
145
.  For a more detailed 
comparison of the effects of graded and uniform Rac activation, we exposed state II cells 
to a rapamycin gradient for 2 hours, subsequently followed by uniform stimulation (2 
nm) for 3 hours thereafter. As expected, cells polarized and moved in a biased fashion 
during gradient stimulation; however upon the switch to uniform stimulation, cells started 
forming protrusions at the rear and showed a decrease in the length of the front (Fig. 
3.6a-d). This effect indicated the importance of persistent gradient input but might also 
reflect a gradual saturation of rapamycin binding sites after prolonged treatment. We 
explored the latter possibility by running the converse experiment, exposing cells to 
spatially uniform rapamycin (2 nm) for 2 hours followed by a rapamycin gradient for 3 
hours (Fig. 3.6e). Protrusions developed on both sides of cells during uniform 
stimulation, and subsequently could not be biased by the gradient (Fig. 3.6e). However, 
cells exposed to a lower uniform stimulation (1 nm) were able to polarize towards the 
ensuing rapamycin gradient  (Fig. 3.6f). In combination, these results indicate that cells 











Fig. 3.6: Comparison between graded and uniform rapamycin stimulation. 
 
(a) Cells exposed to a uniform concentration of rapamycin (2 nM) flatten and do not show 
any directed polarity. (b) Cells observed for one hour without stimulation and 
subsequently exposed to a gradient of rapamycin for a two hour period, followed by a 
switch to a uniform stimulation (2 nM) for three hours. The gradient directs cell motility 
and amplifies the existing lamellipodium. The switch to a uniform stimulation leads to a 
protrusion formation in the rear of the cell and retraction of the previously amplified 
lamellipodium. Times in minutes. Scale bars, 10 µm. (c) A kymograph taken from the cell 
center (specified in accompanying image) depicting the morphological changes of the cell 
shown in panel (b) over various treatment periods. The blue line traces the front of the 
polarized cell, whereas the red line traces the unpolarized face. (d) Quantification of the 
length changes in cell front and back during the rapamycin gradient exposure and after the 
switch to uniform rapamycin stimulation. Numbers indicate total number of cells. Error 
bars are SEM. (e-f) Cells observed for one hour, exposed to uniform 2 nM rapamycin (e) 
or uniform 1 nM rapamycin (f) for two hours, and a gradient for three hours. Cells given a 
2 nM uniform dose exhibit protrusions on both sides, while cells given a 1nM uniform 
dose can still be guided by the gradient. Yellow arrows indicate initial and final enhanced 
protrusions. Times are in minutes. Scale bars, 10m. 
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does not exceed a saturating level. Below, we explore the effects of the rapamycin dose 
and exposure time on cell responses in greater detail. Our results suggest that the spatial 
restriction of Rac activity within a cell is important for maintaining polarization.  
 
3.2.3  Mathematical modeling of graded Rac inputs 
 
 To better address the simplified, yet non-intuitive, nature of our imposed graded 
Rac signaling, we developed a mathematical model of cell polarity. The model is based 
on a simple scheme of Rac-RhoA-Cdc42 small GTPase and Phospoinositide  interactions, 
expanding on earlier modeling studies
167, 168
 (Modeling details found in Supporting 
Information). The model made three important qualitative predictions: a) a spatially 
graded activation input can trigger initial polarization of Rac activity (Fig. 3.7a), b) the 
timing of that initial Rac polarization is strongly dependent on the input gradient  and 
weakly dependent on the average input (Fig. 3.7b), and c) antagonism between the 
activities of Rac and Rho small GTPases can trigger a phase transition-like  change to a 
substantially more asymmetric polarization, which can be stably maintained as long as 
the activity of Rac remains high enough (Fig. 3.7a). This transition will be addressed in 
more detail below. See Supporting information for model details. These predictions could 

















Fig. 3.7: Analysis of the initial response time. 
 
(a) Sample kymograph of the mathematical model simulation under graded Rac 
stimulation. (b) Model response time vs. normalized gradient (s1) for two different values 
of so (input). (c-e) Kymographs chronicling typical changes in cell morphology seen 
during early time periods. The first image before each kymograph depicts the gradient 
(red) that the cell is experiencing as visualized with Alexa 594 dye. The gradient is not 
shown in resulting images to promote clarity of morphological changes. The green color 
indicates expression of YF-TIAM1. Red dotted lines highlight evolving cell boundaries. 
Yellow arrows indicate initial polarities. Times are in minutes. Scale bars, 10 m. (f) The 
dependence of initial response times on gradient values. States are color coded; state I 
(green) n = 29, state II (blue) n = 37, and state III (red) n = 27. In each plot, the colored 
dots highlight the dependence of that particular state while the grey dots illustrate where 
the response times of the other states fall. Data is fitted based on simulation results. 
Spearman correlation coefficient, State I = -.679, State II = -0.655, State III = -0.583. The 
asterisk indicates a statistically significant difference (State II vs. State I, p < 1e-4, State II 
vs. State III, p < 1e-3) between the state II curve vs. the other states. There is no statistical 





3.2.4  Analysis of Rac gradient steepness on timing of cellular responses 
 
 To validate the model predictions, we next examined the correlates of the 
initiation of directed cell migration and their dependencies on the local gradient and 
average value of rapamycin input. HeLa cell responses were characterized by either the 
retraction of a leading lamellipodium in cells polarized in the direction opposite that of 
the gradient (state III), or extension of a pre-existing (state II) or new (state I) 
lamellipodium in the direction of the gradient (Fig. 3.7c-e). To quantitatively evaluate 
these effects, we examined the width and length of the front and rear sides of cells in all 
states through the entire stimulation period, along with the respective concentrations 
experienced at each side (Fig. 3.8). Cells that exhibited bipolar phenotypes (state IV) 
were relatively rare (Fig. 3.1f and Fig. 3.2b) and therefore were excluded from 
subsequent analysis. Our analysis revealed that these initial directed migration response 
times, in agreement with the model predictions, were indeed inversely dependent on the 
steepness of the rapamycin gradient across each cell (Fig. 3.7f). This trend was seen 
across all polarity states (Spearman correlation coefficients; -0.679, -0.655, and -0.583 
for state I, II, and III, respectively). Similar dependencies were also observed in MTLn3 
cells (Fig. 3.9a-c).  The initial response times of state I cells also showed a discernible 
but much weaker dependency on the average rapamycin concentration, consistent with 
the model predictions. Cells in states II and III had relatively weaker dependencies 













and III, respectively). State II cells had consistently shorter initial response times for any 
given gradient steepness when compared to those in state I and state III (Fig. 3.7f and 
Fig. 3.11) (F test- State II vs. State I, p < 0.0001, State II vs. State III, p < 0.001), while 
state I and III cells behaved similarly (State I vs. State III, p = 0.54). For example, when 
comparing the average initial response times at a gradient of .01nm/m +/- .001, state II 
cells had an average initial response time of 51 minutes, while state I had an average of 
98 minutes and state III had an average of 71 minutes.  These results suggest that cells are  
Fig. 3.8: Tracking changes in cell morphology to assay the initial response time.  
 
The plots correspond to the cells in different states, as seen in Figure 2. Various morphology 
metrics are illustrated in the schematic accompanying the graphs. Fractional values of the 
metrics are shown, with values normalized to those at the beginning of the analysis. (a-c) 
Tracking of changes in the lengths of the cell front and back over time during gradient 
stimulation. (d-f) Tracking of changes in widths of the cell front and back. The time to 
reach 20% of the maximum magnitude of the first morphological response to gradient 
exposure was taken as the initial response time. The drop line indicates the initial response 












able to rapidly make migration decisions in the presence of Rac activity gradients 
overlapping with their initial polarization state. Together, our data demonstrates that the 
magnitude of active Rac gradients can influence the timing of the onset of directed cell 
motility. 
 
 Besides the initiation of biased cell migration, the spatially graded activation of 
Rac eventually triggered a striking enhancement in cell polarization, with a substantial 
enlargement of the directed leading lamellipodium (Fig. 3.12a). This morphological  
Fig. 3.9: Initial response and late polarization times of MTLn3 cells. 
 
The plots correspond to the cells in different states, as seen in Figure 2. Various morphology 
metrics are illustrated in the schematic accompanying the graphs. Fractional values of the 
metrics are shown, with values normalized to those at the beginning of the analysis. (a-c) 
Tracking of changes in the lengths of the cell front and back over time during gradient 
stimulation. (d-f) Tracking of changes in widths of the cell front and back. The time to 
reach 20% of the maximum magnitude of the first morphological response to gradient 
exposure was taken as the initial response time. The drop line indicates the initial response 












change was unexpected, but was consistent with the model prediction that crossing a 
threshold of Rac activity triggers a rapid, strong and stable polarization, akin to a phase 
transition. According to the model, a gradual variation of the Rac GEF level caused an 
abrupt transition from a moderately polarized to a highly polarized state, expressed 
mathematically as a bifurcation in the model response (Fig. 3.12b).  We hypothesized 
that our use of low rapamycin concentrations allowed us to observe the effect of a 
gradual titration of intracellular Rac GEF and Rac activity levels leading to this strong 
Fig. 3.10: Additional information on dependence of the initial response time and 
late polarization time on rapamycin gradient and local concentration values.  
 
(a-c) The relationship between initial response time and mean rapamycin concentration for 
all states. Spearmann correlation coefficient values for each curve were determined as 
follows, state I: -0.582 (a), state II: -0.478 (b), state III: -0.377 (c).   (d-f) Late polarization 
times determined for different gradient values for cells in all states. Pearson correlation 
coefficient values for each curve were determined as follows , state I: 0.103 (d), state II: -
0.511 (e), state III: -0.228 (f). Within each plot, the data is binned into three mean 














mathematical representation of accumulation of Rac GEF concentration over the duration 
t of exposure to rapamycin is  
 




Fig. 3.11: State II cells undergo the initial response faster than cells in other states.  
 
(a-c) Examples of the morphological changes in cells in different states experiencing the 
same gradient of rapamycin (0.01 nM/µm +/- 0.001). Cells were exposed to the gradient for 
the entire experimental period but only the 5 minute image showing both cells and the 
gradient visualization is shown for each state to add clarity. Yellow arrows indicate initial 
protrusions. Times are in minutes. Scale bars, 10 µm. (d-f) Quantification of the 
morphological changes seen in the examples shown in (a-c). The dropline indicates the 
initial response time. The circle indicates the metric used to determine it, with the color of 

















Fig. 3.12: Analysis of the late response time. 
 
(a) Kymograph depicting the change in the lamellipodium directed by the gradient and 
dimming seen in the cell body during the late polarization time. The image preceding the 
kymograph illustrates the gradient (red), visualized with Alexa 594, received by the cell. 
The green color visualizes expression of YF-TIAM1. Red dotted lines indicate where the 
fluorescent values in c are taken from. Times are in minutes. Scale bar, 10 m. (b) 
Simulations showing response strength vs. input (so) for two gradient levels (s1); note 
bifurcations at distinct so values. Response strength is defined as the ratio of Rac activity at 
the front vs. the back in the model cell.  (c) The intensity of the cell body normalized to the 
initial time point. Intensity values are taken as the mean of the fluorescence intensity of the 
area enclosed by the red trace in a. The drop line indicates the late polarization time, with a 
circle highlighting the inversion of response used to define this time. (d) 3D reconstruction 
of confocal slices of the same cell taken pre- and post- rapamycin addition. The “post-“ cell 
image was taken 240 min after treatment. Scale bar, 10 m. (e) Cell body volume before 
and after rapamycin addition. The data shows the mean of n = 9 cells and error bars show 
SEM. The asterisk denotes a statistically significant difference, p = 0.019, using a two sided 
student’s t-test (f) The late response time as a function of mean concentration. State I 
(green) n = 29, state II (blue) n = 37, and state III (red) n = 27. The response times of other 
states are superimposed on each plot in grey. The pink drop line in the state III plot 
demarcates the separation point between unresponsive cells and responsive cells. Pearson 
correlation coefficient of linear regressions- State I = -0.608, State II = -0.783, State III = -
0.698). The red asterisk denotes a statistically significant difference (state II vs. state I, p < 
1e-4, state II vs. state III, p < 1e-4) between the y intercept of the linear regression for state 
II vs. the y intercepts of the regression data from other states. There is no significant 
difference between the y intercept of state I vs. state III (p = 0.13). Both statistical tests were 





where k is the constant defining tripartite rapamycin-FKBP-FRB complex formation. 
This expression allowed us to test the hypothesis of the existence of a Rac activity 
threshold mediating enhanced polarization.  
 
 One of the immediate consequences of the expansion of the lamellipodium in the 
direction of the rapamycin gradient was an apparent dimming of the YFP fluorescence 
signal from the cell body when observed with a wide-field epi-fluroescence microscope 
(Fig. 3.12a,c). The dimming of the fluorescence intensity was likely due to a 
redistribution of cytoplasmic volume from the cell body to the expanding lamellipodium 
and an increase in the translocation of YF-TIAM1 complexes to the membrane (Fig. 
3.12d-e). We thus used the fluorescence intensity of the cell body as a metric for the 
timing of late polarization.   Our analysis indicated that the late polarization time 
exhibited a linear dependency on the average local rapamycin concentration (Fig. 3.12f) 
(Pearson correlation coefficients; -0.608, -0.783, and -0.698 for state I, II, and III, 
respectively), in agreement with model predictions. MTLn3 cells also showed similar 
dependencies on mean rapamycin concentrations (Fig. 3.9d-f).  A weaker dependence on 
the sharpness of the rapamycin gradient, consistent with the model, was also detected in 
these experiments (Fig. 3.10d-f) (Pearson correlation coefficients; 0.103, -0.511, and -
0.228 for state I, II, and III, respectively).  As with observations of early cell responses, 
state II cells reached the late polarization phase significantly faster than cells in other 
states for a given rapamycin concentration (Fig. 3.12f and Fig. 3.13) (ANCOVA test of y 
intercept, State II vs. State I, p <0.0001, State II vs. State III, p<0.0001) while the 











also found that a sub-population of state III cells exposed to lower concentrations of 
rapamycin completely failed to reach late polarization (Fig. 3.12f). In combination, these 
results suggested the existence of a threshold for late polarization, variable across 
individual cells and dependent on the initial polarity state. 
 
3.2.5  Transient graded Rac activation 
 
 Equation (1) suggests that the duration of rapamycin exposure is as critical as the 
Fig. 3.13: State II cells undergo the late polarization response faster than cells in 
other states.  
 
(a-c) The late polarization response of cells in all three states experiencing the same 
concentration gradient and the same local concentration of rapamycin. Yellow arrowheads 
indicate the direction of initial cell polarity. (d-f) Quantification of the average fluorescence 
intensity in cell bodies of the cells shown in (a-c) (see the schematic for the cell body 
definition). Drop lines indicate the late polarization times for each example. Note that the 
cell in state II reaches the late polarization phase faster than the cells in the other two states. 





local rapamycin concentration in exceeding the polarization threshold.  Based on in vitro 
estimates of rapamycin-FKBP-FRB complex formation, the characteristic binding time 
estimated for 1 nM rapamycin is in the range of tens of minutes
162
. To test this prediction, 
we varied the time interval of rapamycin stimulation, taking into account the earliest 
polarization time observed for the rapamycin concentrations tested, i.e., 30 min and the 
estimated equilibration time above.  We exposed cells to transient rapamycin gradients of 
0.01 nM/m for 30 min or 1 hr, followed by perfusion of the devices with rapamycin-free 
media for the rest of the experiment. We found no cells undergoing late polarization after 
a 30 minute rapamycin gradient exposure (Fig. 3.14a-c), however, after a 1 hr 
stimulation, we found subsets of cells in all polarity states able to undergo late 
polarization, provided that they were exposed to sufficiently high concentrations of 
rapamycin (Fig. 3.14d-f). The polarization responses were morphologically similar to 
those seen earlier during continuous stimulation (Fig 3.14d,e), with the timing to late 
polarization indistinguishable from those observed for continuous stimulation (Fig. 
3.14f). Responding cells continued to polarize even after the stimulus was withdrawn, 
suggesting fixation of the induced polarity and migration states (Fig. 3.14d-e), in contrast 
to their loss during the transition to spatially homogeneous Rac activation (Fig. 3.6).This 
behavior was in agreement with model predictions of a stable polarization beyond a Rac 
activity threshold which enables cells to maintain a strongly polarized state whose 
direction is based on but not continuously informed by the input gradient. Using a 
classification algorithm to separate responding and non-responding cells, we found that 
the minimum concentrations needed to elicit a response varied across the polarity states 













cells, cells in this state possessed the lowest response threshold (Fig. 3.14f) (State I= 1.5 
nM, State II = 1.1 nM, State III = 1.4 nM). These data further support the existence of a 
Fig. 3.14: Overcoming a Rac activity threshold determines the late polarization 
time. 
 
(a,d) Time series of representative cells stimulated with a gradient of rapamycin for 30 
minutes and 60 minutes respectively. Yellow arrows indicate the initial direction of cell 
polarity. Times are in minutes. Scale bars, 10 m. (b,e) Kymographs taken from the center 
of cells (specified in accompanying image) illustrating morphological changes seen in a,d 
respectively. Blue lines track the initially polarized cell face while red lines track the 
opposite face. Below the kymograph is the experimental scheme used to stimulate the cell. 
(c,f) Late polarization time for a 30 minute and 60 minute stimulation period for all three 
states, respectively. For 30 minutes- State I (green) n = 17, state II (blue) n = 13, and state 
III (red) n = 31. For 60 minutes- State I (green) n = 32, state II (blue) n = 37, and state III 
(red) n = 32. Diamonds indicate cells that did not respond within the experimental time 
frame (240 minutes), while circles indicate responsive cells. Grey dots in each plot represent 
the late polarization times for cells in each state from Fig. 3f. The drop lines demarcate a 





well-defined, initial polarity-dependent, Rac activation threshold essential for the rapid 
and profound induced changes in polarized cell morphology. 
 
3.2.6  Inhibition of upstream activators 
 
 Direct activation of Rac allows bypassing of many signaling species commonly 
thought to be either upstream of Rac or involved in a regulatory feedback with this 
molecule. A well studied example of such a molecule is phosphatidylinositol 3,4,5-
triphosphate (PIP3)
145, 169, 170
. In chemoattractant gradients, phosphatidylinositol 3-kinase 
(PI3K), is recruited to the plasma membrane and phosphorylates the abundant 
phosphatidylinositol 4,5-bisphosphate (PIP2) to yield PIP3 (2, 43). Due to spatial 
regulation of PI3K recruitment, PIP3 is often enriched at the front areas of migrating 
cells
78
, displaying an intracellular gradient that is sharper than the gradient of the 
extracellular chemoattractant
142, 171
. It is thought that PI3K can influence cell guidance 
through its interaction with small GTPases and actin, but the mechanism of these 
interactions and the resultant role of PI3K in regulating chemotaxis are still under 
investigation
12, 13
. If, as sometimes assumed, PI3K is upstream of Rac activation in 
chemotactic signaling systems, its perturbations are not expected to lead to alteration of 
cell response to rapamycin-based Rac GEF stimulation. If, on the other hand, PI3K forms 
a feedback loop with Rac
143, 145, 150
, or otherwise enables Rac-mediated outputs, cell 
responses might be affected by its inhibition, with the change in cell behavior potentially 
suggesting the mechanism of PI3K regulatory involvement. We used a pharmacological 
inhibitor of PI3K, LY294002, to inhibit PI3K activity during gradient stimulation with 
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rapamycin. As a control, we first observed the effects of LY294002 with and without 
rapamycin on basal cell motility and found no significant effects (Fig. 3.2d,e). After 
induction of the gradient, in contrast to the responses of cells in which PI3K was not 
perturbed, we observed large subsets of cells exhibiting no response, both in terms of the 
initial and late polarization, for all three initial polarity states across various gradients and 









Fig. 3.15: PI3K modulates Rac mediated polarization. 
 
(a) Late polarization time dependence against mean concentration with LY294002 
treatment. State I (green) n = 21, state II (blue) n = 31, and state III (red) n = 27. Diamonds 
represent non-responder cells while circles represent responding cells. Grey dots on each 
plot illustrate the late polarization times seen in Fig. 3f. The grey drop line in the state III 
cell response plot represents the previous response threshold between non-responding and 
responding untreated cells, while the colored line represents the shifted threshold following 
LY294002 treatment.  (b) Model schematic as in Model Figure 1 with red ‘X’ indicating 
that feedback from PIP3 (f1) is decreased during the subsequent simulations. (c) Simulations 
of response strength vs. signal strength for different feedback levels (In all previous 




migration and late polarization responses did so with the same kinetics as observed in the 
absence of PI3K perturbation (Fig. 3.15a).  This was consistent with the model prediction 
that a decrease in simulated strength of the PI3K-mediated feedback to Rac could lead to 
an increased threshold for cell responsiveness, requiring a sharper effective internal Rac 
activity gradient for cells to respond (Fig. 3.15b-c). As a consequence, the stochastic 
differences in internal states of the cells, defining cell sensitivity to the graded signaling 
input, can lead to a greater degree of cell population separation into responding and non-
responding cells, without affecting the timing of responses in responding cells. 






Fig. 3.16: Suppression of polarization responses with LY294002 treatment. 
 
(a-c) Time lapse imaging of sample cells selected from subpopulations in different states 
during LY294002 addition.  LY294002 was included at a concentration of 10 µM and was 
included in both cell medium solutions used to generate the rapamycin gradient. In all 
examples shown, cells fail to respond within the experimental time frame across all states. 
Yellow arrows indicate the direction of the initial cell polarity. Times are in minutes. Scale 
bars, 10 µm. (d) Initial response time vs. rapamycin gradient values in cells responding in 
the presence of LY294002. State I (green) n = 21, state II (blue) n = 31, and state III (red) n 
= 27. Diamonds represent non-responder cells while circles represent responding cells. Grey 






The results in Fig. 3.12f suggested the existence of a relatively high (re-)polarization 
threshold for state III cells. Thus we explored whether there would be synergy between 
this threshold and the increase in polarization threshold caused by inhibition of PI3K. We 
found that this threshold was indeed shifted in the presence of PI3K inhibition to a higher 
rapamycin concentration level (Fig. 5d) (1.0 nM for untreated state III vs. 1.4 nM for 
LY294002 treated state III). These results thus support the notion that PI3K can serve to 
sensitize cells to spatially graded Rac activation, allowing them to more readily exceed 




 The results presented in this report argue that directly induced, spatially graded 
membrane translocation of a Rac activator, TIAM1, can trigger unambiguous polarization 
and directed movement of cells aligned with the direction of the stimulation gradient. 
TIAM1 is a specific Rac GEF
172
 and another key regulator of polarity, CDC42, is 
considered upstream of Rac
62
, therefore we attribute our observed phenotypes to be 
originating from direct Rac activation. The gradients of the inducer of Rac activation, the 
exogenously added rapamycin, can be effective with values as low as 15% across the cell 
length, with the rates of cellular responses to the stimulation being defined by the 
gradient steepness. The results suggest that even mild initial Rac GEF gradients can 
trigger strongly polarized cell responses, potentially providing insights into the levels at 
which graded inputs can be amplified in the signaling network. However, the response 
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kinetics can be enhanced with sharper input gradients (Fig. 3.7f) or if these gradients are 
amplified upstream of Rac activation.  
  We propose that rapamycin induced graded Rac activation can induce 
qualitatively similar polarization responses to those seen in chemoattractant gradients. 
For example, state I cells exhibit an initially low, mostly homogeneous Rac activity 
followed by the induction of high Rac activity at a newly formed front when a gradient of 
rapamycin is applied. This pattern of Rac activity is similar to that seen in neutrophils 
polarizing to a gradient of fMLP
173
. Additionally, state III cells repolarize when given 
sufficiently high gradients of rapamycin by forming a new front at the rear and retracting 
the previous front. This behavior is seen when chemoattractant gradients are presented at 
the rear of polarized cells through microfluidics or micropipette. Chemoattractant 
induced repolarization can be seen in neutrophils
174
, social amoebae 
175
, and breast cancer 
cells
79
. Given that rapamycin induced graded Rac activation can mimic polarization 
behaviors seen with chemoattractant gradients, we believe that polarization can be 
defined at the level of Rac or at least starting from the level of Rac.  
 The research platform described here enabled the screening of the effects of a 
slow variation in the total cellular Rac activity. Both a simple model describing a 
feedback-based interplay between small GTPases in a cell and the corresponding 
experimental observations support the novel finding that a rapid and pronounced 
transition to a much stronger degree of polarization can occur if Rac activity exceeds a 
threshold level. This threshold was found to be strongly affected by the initial 
polarization status of the responding cell. Cells initially polarized in the direction of the 
applied gradient on average have lower response thresholds than cells that are 
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unpolarized or polarized in the opposite direction. Moreover, only a fraction of cells 
initially polarized away from the gradient responded to the gradient of Rac activator.  
These results are consistent with the following view supported by the model: an existing 
endogenous gradient of Rac activity in state II cells would lead to a smaller difference 
between the maximum local initial Rac activity within a cell and the polarization 
threshold value.  
  Our results further suggest that signal processing upstream of Rac activation in 
the context of chemoattractant stimulation may limit the degree of total Rac activation 
and thus the ability of the cell to reach the threshold controlling transition into the 
strongly polarized state. Thus, a single ligand may not induce such a transition. However, 
the threshold might potentially be reached and exceeded given multiple inputs 
converging on Rac activation, which may be affected by cell type-specific peculiarities of 
the signaling apparatus, such as basal levels of Rac activation and the expression of the 
signaling proteins.  
 The rapamycin stimulation system described here also allows a more detailed 
study of the interplay between Rac activation and activity of other signaling species, 
including those that might be involved in various feedback interactions. This analysis is 
akin to the more common epistasis assays, but with subtler phenotypes related more 
closely to gradient sensing responses. In particular, our analysis suggested that PI3K 
interplay with Rac activation, while consistent with the recently proposed formation of an 
AND gate in terms of the response
145
 where both inputs are necessary to induce directed 
migration, acts more specifically by controlling the threshold of cell responsiveness to 
Rac activity gradients. Whereas PI3K inhibition does not prevent the ability of the cells 
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to undergo directed cell polarization or migration responses, it can strongly reduce the 
fraction of cells capable of these responses within the same set of experimental 
conditions.  
 The analysis here represents a more general framework extensible to other 
rapamycin-activatable signaling molecules
157, 176, 177
, as well as other cell types and 
multicellular systems. Furthermore, the effects of gradients of other proteins engineered 





, could also be analyzed to refine our understanding of the mechanisms of 
cell responses to graded intracellular signaling activity. As also demonstrated in this 
report, such efforts could help develop qualitatively and quantitatively improved 
mathematical and computational models of gradient sensing and chemotaxis phenomena, 
extending common approaches to these processes. We suggest that, as the repertoire of 
methods for direct control of cellular events increases, microfluidics-based tools will play 
an important role in exploitation of these methods in cell navigation research.  
 
3.4 Materials and Methods 
 
3.4.1  Modeling 
 
 We have developed a simple model based primarily on the antagonistic 
relationship between the two small Rho family GTPases involved in polarized cell 
migration, Rac and Rho, modulated by Cdc42, based on sequential model selection. The 
model was implemented as a system of partial differential equations (PDEs) for Rho 
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GTPases in 1 space dimension and explored numerically using Matlab® (MathWorks).   
(See 3.4.14 for details). 
 
 
3.4.2  Device fabrication 
 
 Microfluidic chips were created using a two layer soft lithography process
116
.  
PDMS (GE RTV) was used to create molds for the devices as described previously
180
. To 
increase the height of the flow through channels, the membrane between the control layer 
and flow layer was removed. Before an experiment, each device was treated with HCL, 
cleaned with 70% ethanol, and was allowed to bond to a clean 22x40 mm coverslip 
(Fisher).  
 
3.4.3  Cell culture and transfection 
 
 HeLa cells were maintained in Dulbecco’s modified Eagle’s medium with 10% 
FBS and 1% Penicillin Streptomycin (Gibco). MTLn3 cells were cultured in Alpha 
minimum essential medium supplemented with 5% FBS and 1% Penicillin Streptomycin 
(Gibco). Both cell lines were kept in a 37°C and 5% CO2 environment during culture and 
in experiment. MTLn3 cells were kindly provided by the Segall lab. The constructs, YF-
TIAM1, YF, and Lyn11-FRB were transfected into cells using Fugene HD (Roche) per 
manufacturer’s recommendations. The Raichu-Rac FRET probe was kindly provided by 
the Matsuda lab and was transfected in a similar manner. During FRET experiments, MF-
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TIAM1 was used in place of YF-TIAM1. MF-Tiam1 has a mCherry fluorophore in place 
of YFP and was used to avoid spectral overlap with the FRET probe.  
 
3.4.4  Imaging 
 
 Microfluidic experimental imaging was performed using an inverted Zeiss 
Axiovert 200M epifluorescence microscope under 37°C and 5% CO2, coupled to a 
Cascade II:1024 EMCCD camera (Photometrics) using a 40x, 1.3 numerical aperture oil 
immersion objective (Zeiss). The microscope was driven by Slidebook software 
(Intelligent Imaging Innovations). Images were taken every 5 minutes in the YFP channel 
using a 494 nm excitation filter and 530 emission filter set (Semrock) and Alexa 594 dye 
was imaged using a 572 nm excitation filter and 628 emission filter (Semrock) over a 
four hour period.  A spectral 2D template autofocus algorithm was employed between 
images to account for any focus fluctuations. To correct for uneven illumination, all 
images were normalized with the following correction C = (I-D/F-D)*M where C = 
corrected image, I = initial image, D = darkfield image, F = flatfield image, and M = 
mean of difference between flatfield and darkfield images. The flatfield and darkfield 
images were taken as averages of multiple images. FRET images were taken using using 
a CFP excitation filter (Semrock), an appropriate dichroic (Semrock), and a YFP/CFP 
emission filters (Semrock).Volume analysis was performed on an inverted Zeiss Axiovert 
200 spinning disk confocal microscope, coupled to a CCD camera (Hamamatsu) using a 
40× objective (Zeiss). The microscope was driven by Metamorph 7.5 imaging software 
(Molecular Devices).  YFP excitation was trigged with an argon laser (CVI-Melles Griot) 
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which was fiber-coupled (OZ optics) to the spinning disk confocal unit (CSU10; 
Yokogawa) mounted with a YFP dichroic mirror (Semrock) and an appropriate YFP filter 
(Chroma Technology). 
 
3.4.5  Analysis of gradient and mean values of rapamycin 
 
 All analysis was performed using custom written codes in Matlab 2007b 
(Mathworks). Cell-based data (Cell length, centroid, etc.) was obtained from the YFP 
images while gradient based data was obtained from the Alexa 594 dye images. Cells 
were segmented from the YFP channel based on intensity. The signal to noise ratio was 
sufficiently high to preclude the use of more sophisticated segmentation techniques. Once 
cell boundaries were determined from the segmentation, concentration lines spanning the 
width of the channel were generated from the front and back of the cell to obtain local 
concentration data. The concentration lines were restricted to the width and length of an 
individual channel by manually selecting the boundaries of the channel from the Alexa 
594 dye image. For any cell that extended out of the channel, the concentration lines were 
restricted to the respective ends of the channel to avoid spurious measurements associated 
with the height difference between the arms of the flow channels and the cross channels. 
Dye intensities were extrapolated to the intensities at the respective ends of the channel to 
determine concentration. 
 




 Cell velocity was tracked by obtaining the coordinates of cell nuclei using a semi-
automated script written in Matlab.  
 
3.4.7  Quantification of the membrane distribution of YFP-FKBP 
 
 The translocation of YFP-FKBP to the membrane was quantified by taking the 
ratio of intensities at the cell periphery to the intensity in the cytoplasm. First, the 
cytoplasm and membrane were segmented by intensity thresholding from cell images and 
a subsequent morphological erosion was used to obtain each component separately. To 
obtain the membrane intensity across the cell length, the max value of each row of pixels 
in the membrane segmentation was taken.  The cytoplasm intensity was obtained by 
taking the mean value of each row of pixels from the cytoplasm segmentation. Ratio 
values across the length of the cell were normalized between 0 and 1 and smoothed with 
a 10 point moving average. To aggregate data from multiple cells, time 0 was chosen as 
30 minutes before visible translocation and subsequent profiles were normalized to 
values at time 0. For control cells, time 0 was chosen at times comparable to cells 
positioned in similar locations during rapamycin experiments.  
 
3.4.8  FRET analysis 
 
 FRET analysis was done according to a previously described protocol
181
. Briefly, 
FRET images were analyzed by first subtracting background from each individual CFP 
and YFP FRET image (CFP excitation, YFP emission). Images were thresholded and  
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subsequently aligned with a dft registration algorithm
182
. The FRET ratio was calculated 
by dividing the YFP FRET image by the registered CFP image. Final images were 
Gaussian filtered to remove noise. To obtain the distribution of FRET activity across the 
cell length, the mean value of each row of pixels composing the ratio image was taken 
and final values were normalized between 0 and 1 for the cell length and smoothed with a 
10 point moving average. To aggregate data from multiple cells, time 0 was chosen as 30 
minutes before the appearance of morphological changes in accompanying MCHF-
TIAM1 images. FRET profile data in later time points were normalized to time 0. For 
control cells, time 0 was chosen based on comparably located stimulated cells.  
 
3.4.9  Volume analysis 
 
 Cell heights were generated by first taking calibrated Z slices of cells before and 
after rapamycin treatment. Afterwards, each slice was segmented and the summation of 
slices was used to generate the final image. The cell volume was determined by taking a 
region of interest (ROI) in the cell body from 3D reconstructions carried out using 
Matlab. The number of p -
calibration of the slice height.  
 





 All measurements were performed using Matlab. To determine the length of a 
cell’s front and back, the cell nucleus was tracked by manually fitting an ellipse to the 
nucleus image and taking the centroid of the fitted ellipse as the position of the nucleus. 
Nuclei were clearly distinguishable in all YFP images analyzed due to exclusion of the 
construct. Cell front and back lengths were calculated by taking the coordinates of the 
front and rear of cells from segmented images and calculating the distance to the nucleus 
position (SI Appendix (Fig. S6)). To assay the width of the front and rear of each cell, the 
distance between the rightmost and leftmost coordinates of the cell front (top 10% of 
pixels) and rear (bottom 10% of pixels) were calculated (SI Appendix (Fig. S6)). The 
initial response time was taken as the time to reach 20% of the total magnitude of the first 
morphological change towards the gradient (SI Appendix (Fig. S9)). The initial response 
time was taken at the 50% level for MTLn3 cells due to the faster kinetics associated with 
their responses. To find the late polarization time, the decrease in fluorescence of the cell 
body was measured as a function of time. The fluorescence intensity was determined in 
ROIs, chosen automatically based on the end coordinates of the cell (front and back) (SI 
Appendix (Fig. S10)). The ROIs were then further eroded by several pixels to avoid any 
effects from the cell membrane. The late polarization time was taken as the time to reach 
50% of the full fluorescence intensity drop in the ROI from the peak intensity value.  
 
 




 Thresholds between non-responding cells and responding cells were determined 
using quadratic discriminant analysis (‘classify’ function) in Matlab. The two populations 
along with their corresponding concentrations were input into the function as training 
data and a separation point was generated from a given vector of concentrations.  
 
3.4.12  Statistical analysis 
 
 Statistical analysis was carried out with Sigmaplot software (Systat) and 
Graphpad Prism (Graphpad). Experimental results were expressed as means with error 
bars equal to standard error of the mean (SEM). Comparisons between two groups were 
carried out with a two sided student t-test when assumptions of normality were fulfilled. 
For comparisons which did not satisfy the assumption of normality, a Mann-Whitney 
Rank Sum test was used. Comparisons were deemed to be significant if p values were < 
0.05. The comparison between the y-axis intercepts of the linear regressions of the 
relevant data points was carried out using an analysis of covariance test (ANCOVA). 
First, the difference between slopes was compared; if the difference was insignificant, a 
comparison between the y-axis intercepts was performed. To compare fitted curves, an F-
test was conducted, using the standard procedure.  
 
3.4.13  Model methods 
 
 As described in our previous computational article
183
, our model (shown in Fig. 
3.17) is related to previous work
167, 184
. It was assembled in several stages, with 
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modifications and geometric considerations relevant to the specific experimental system 
described in the main text of this paper. Here, we provide a brief description of the 
ultimate model and how it was analyzed. 
 We consider the three GTPases implicated in polarized cell morphology, control, 
and chemotaxis, Cdc42, Rac and Rho (While in principle similar results are obtained 
without Cdc42, this master signaling component was included for completeness). For 
each GTPase, we track the levels of active and inactive forms bound to the membrane, G, 
G
mi
, as well as an inactive (GDI- bound) cytosolic form G
c
 , (where G = C, R,  represent 
Cdc42, Rac and Rho concentrations). Each variable is a function of time t and position x 
in a given cell. See below for details of the cell geometry. We assume that an inactive 




 and that 
GEF/GAP activity interconverts the membrane bound species G
mi
, G. We integrate over 
the depth direction (see below). Every point in the resulting domain is considered to have 
both cytosolic and membrane components. Crosstalk shown in the figure is directed at 
GEFs, with enhanced/reduced GEF activity depicted by arrows/inhibitory connections. 
Linear GAP activity is used in all cases. For phosphoinositides, we track PIP, PIP2, and 
PIP3 (whose levels are denoted P1 , P2 , P3 ), Their interconversions, mediated by kinases 
and phosphatases) are assumed to be enhanced by Rac or Rho as indicated in the 
schematic (Fig. 3.17). The feedback from the PIP layer to the GTPase layer is governed 









1.2. Small GTPase module. Equations for each of the active (membrane bound) and  
 
 












































where Dm, Dc are membrane and cytosolic rates of diffusion, G is GAP-mediated 
inactivation rate, koff is the membrane disassociation rate constant, and kon the membrane 
association rate constant. The term IG is GEF-mediated rate of activation that depends on 
the availability of inactive GTPase, and on crosstalk from other active species. Rates of 
diffusion in membrane and cytosol are estimated as Dm = 0.1 µm/s
2
 and Dc = 100 µm/s
2
 
Fig. 3.17: Diagram of the Rho-GTPase/Phosphoinositide signaling network used in 
the one dimensional spatial cell model. 
 
Activation is denoted by () and inhibition by (). The signal is S(x,t)=so + s1 x / L, where 








. These equations, supplemented with no-flux boundary 
conditions conserve the total amount of each GTPase. 
  
Geometry and simplification. Cells are narrowly confined in microfluidic channels, so 
that their width is constrained and time independent. In view of this fact, it is reasonable 
to approximate cell shape as a 3D box of length L, width w, and depth d satisfying d < w 
<< L. Due to controlled signal and the physical constraints of the experimental apparatus, 
it is reasonable to neglect gradients in all but the length direction. Define a 1D projection 









    
 
Here we have approximated G
c
 as nearly uniform across the width and depth directions. 
It follows directly that 
 














Over the timescale considered, the volume of the cell V ≈ w · d · L is roughly constant. 
Channel diameter determines width w, so the observed lengthening of the cell must be 
accompanied by depth change. We take the initial values of d0 = 0.2 µm, L0 = 20 µm for 
a pre-stimulated cell.    As L (but not d) is directly observable experimentally, we use wd 
= V /L to eliminate the less easily measurable cell depth. 
  
A composite inactive form. We consider the cycling of the inactive GTPase between 
membrane and cytosol to be in quasi steady state, as before
167
. We find the fraction of the 
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inactive forms on the membrane and in the cytosol to be be (L) := kon / (kon + [V/L] koff )  
and  
(1-(L)), respectively. A composite inactive form, Gi  , is defined as 
   
(1.6)   ipcimipcmii GLGGLGGGG ))(1(,)(,   . 
 
This accounts for the fact that only the membrane bound fraction of this composite is 
available for GEF activation. We also define an “effective diffusion constant”  
 
(1.7)   .))(1()()( cmmc DLDLLD    
 
This weights the diffusion constant of the composite form according to the proportion of 
time spent on the membrane and the cytosol. A full parameter set is determined by 
assuming Dmc (L0 ) = 50, consistent with previous work(2-4) and kon = 1s
-1
 . koff   is then 
determined by 
 

















completing the parameter set associated with membrane cycling.  
 
Reduced GTPase model. The system is now reduced to a set of three GTPases, each 
described by a single composite inactive form G
i
 (x) and an active form G(x), the total of 
which are conserved over the (1D) domain on the experimental timescale. We use the 
cross-talk depicted in Fig. 3.17 to formulate a system of 6 PDEs. Linear inactivation by 
GAP’s is assumed for each GTPase and up/down regulation of GEF activation pathways 








with G = C, R,  and GEF activation rate functions 
 



































































































A more complete discussion of the forms of these kinetic terms was given earlier
184
. Note 
that n ≥ 2 is required for this system to exhibit appropriate (``wave-pinning”
186
) 
polarization behavior. Normalization by (L0) makes for convenient parameterization. 
Here f1 represents PI feedback strength to the GTPase module via Rac. 
 
Phosphoinositide module. A PI feedback module
168
, modified from earlier work
167
 is 











































































































































Simulation Method. Simulations of the model equations (1.9), (1.10), (1.11) are 
performed with an implicit diffusion, explicit reaction scheme. Initial GTPase profiles are 
spatially uniform. The system is allowed to settle to a (parameter dependent) 
homogeneous steady state by integrating for 50 time units. At t = 50, the signal S(x, t) is 
applied to Rac GEF as shown in Eqn (1.10) and the model is integrated to t = 500. We 
observe that a new polarized steady state emerges on a typical time scale of 100- 300 
time units. In all simulations, the rest state was stable to small amplitude noise. The 
results of a sample simulation are shown in the kymograph of Figure 2a. GTPase 
asymmetry/polarization strength (Figs. 3.12b and 3.15c) is measured as the absolute 
difference between the highest and lowest active Cdc42 (C) levels at the final time. (R or 
 can also be used to quantify polarization with similar results.) Response times, shown 
in Fig. 3.7b, are based on a generic inverse relationship between cytoskeletal 





reorganization rate and GTPase polarization strength, i.e., response time = 1/response 
strength.  
 
Predictions. Here we provide a brief overview of the model, referring the interested 
reader to our companion paper
183
, where a detailed development and analysis has been 
provided. 
 
The model described here, has at its core a polarization mechanism based on a wave of 
activity that sweeps across a cell and freezes to produce a static profile with large 
differences between cell poles. This stalling wave behavior has been termed "wave-
pinning"(5). A key feature of this mechanism is that a threshold stimulus (either localized 
or distributed as gradient or noise) is needed to initiate a response. This feature stems 
from a combination of several factors: (a) active and inactive GTPases diffuse very 
differently due to their membrane (cytosol) residence. (b) The GTPase circuit shown in 
Model Fig. 1 contains an effective positive feedback.  This causes the active GTPase to 
promote nearby activation. (c) Cycling between these forms preserves a constant total 
amount, leading to depletion effects as more and more activity is turned on. This 
ultimately freezes the wave in its tracks. Thus, if a stimulus provokes local activity 
exceeding a threshold, it self-amplifies and spreads, but only so long as inactive GTPase 
is available to be activated. It has been shown that this leads to a plateau of high (low) 
activity at the cell poles, but the details of the mathematical analysis are technical and 




In contrast to the above, many commonly used models for cell polarization (reviewed in 
187
) have no threshold for patterning, and a response is triggered by arbitrarily small 
amplitude noise, here denoted by the informal term “ultrasensitive”. Such pattern 
formation is commonly termed Turing-type. Absence of a stable rest state, makes this 
type of polarization mechanism unsuitable for the HeLa cell system described in this 




To analyze the behavior of models with slow and fast rates of diffusion, we extended a 
recently developed technique termed "Local Perturbation Analysis" in 
183
. This technique 
approximates the reaction-diffusion PDEs with simpler ordinary differential equations 
(ODEs) for the local (slow diffusing) and global (fast diffusing) components of the 
system. The analysis of the resulting LPA system of ODE’s allowed us to (a) find 
interesting parameter ranges and classify the dynamics as wave-type or Turing-type 
behavior, (b) easily explore how changes in model assumptions affect such behavior, and 
(c) understand how inhibition or upregulation influences the behavior of the system. 
 
We used LPA to identify the wave-pinning parameter regime for the model. To 
investigate the experimentally modulated Rac GEF activity levels, we tested the model 
against manipulations of terms corresponding to Rac GEF activity levels. To do so, we 
defined a stimulus, S(x,t)=so + s1 x / L, affecting the Rac GEF term IR, with so the 
background level and s1 the stimulus gradient steepness. (see expression for IR in Eqs. 




We ran several tests with various values of so and s1 and studied how the model responds 
to increases in one of these parameters at various values of the other. We found that so 
modulates the wave pinning response threshold in the PDE model, (Fig. 3.12b). For fixed 
s1, sufficiently large so provokes a response, as expected in the presence of a threshold.  
Further, the higher the background GEF activity level so, the lower the threshold to be 
breached for a response.  Essentially, s0 sets the response threshold, and s1 produces 
spatial heterogeneity in the system.  If s1 is large enough that the solution breaches that 
threshold, a response similar to a phase transition results. The significance of this finding 
is that basal GEF activity levels, which can be modulated either internally by the cell or 




3.4.14  Microfluidic setup 
 
 First, control valves (marked blue in Fig. 3.2a) were primed by connecting 
syringes filled with deionized water and pressurized to 20 psi. Experimental solutions 
were made using DMEM F-12 (Gibco) as a base medium. In a typical experiment, two 
solutions were injected into the device, one containing rapamycin and the other without. 
Rapamycin concentrations in microfluidic chips were titrated to uniform stimulation 
experiments in open chambers by comparing temporal responses. The rapamycin solution 
was injected into inlet “1” (Marked red in Fig. 3.2a). Once the solution reached the 
intersection of the channel and valve “1”, the valve was pressurized to keep the solution 
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pinned at this location. In the corresponding ‘0’ inlet, the rapamycin-free solution was 
injected and allowed to flush through inlets marked ‘wash’ to wash away any rapamycin 
which may have entered into the channel. After the wash period, plugs were placed into 
the “wash” inlets. For experiments utilizing LY294002, a 10 M concentration of the 
drug was introduced into both experimental solutions. In all experiments, a 10 g ml
-1
 
fibronectin solution was injected into the ‘cell’ inlet prior to cell introduction. Actuation 
of valve marked “5” forced the fibronectin solution through the cross channels into the 
right flow through chamber and out of the outlet labeled ‘out’. Fibronectin coating was 
performed for 50 min at 37°C. After the coating period, another rapamycin-free solution 
was placed into the outlet and the fibronectin solution was removed from the ‘cell’ inlet. 




, was injected into the 
‘cell’ inlet with a loading pipette. The outlet pressure was lowered below the atmospheric 
one, causing flow of the cell suspension and subsequent seeding of cells into the cross 
channels via the same principle used above for the fibronectin coating. Excess cells in the 
main flow arms were washed out. In experiments utilizing LY294002, a rapamycin and 
LY294002 free solution was injected into one of the ‘wash” inlets to flush away excess 
cells to prevent prior exposure of cells to the inhibitor. HeLa cells were allowed to attach 







Chapter 4. Interplay between chemotaxis and 





4.1  Introduction 
 
 Directed cell migration is the ability of cells to bias their migration towards or 
away from external cues. It is fundamental to a diverse set of processes, including 
developmental patterning, cancer metastasis, immunity, and wound healing. During 
directed cell migration, several attractant or repulsive cues may act on a given cell 
simultaneously. These cues can arise from the environment or from the surface of similar 
or disparate cell types. For example, during topographic mapping, retinal growth cones 
can be directed by cell contact from a series of cell surface expressed ligands on other 
cell types along with soluble guidance molecules
188
. Alternatively, the directed collective 
migration of neural crest cells is driven by soluble guidance cues and cell repulsion 
between neural crest cells
189, 190
. However, it still remains poorly understood how the 
integration of multiple cues occurs and whether these cues act independently.    
 Another context in which multiple cues may play a prominent role in modulating 
directed cell migration is in the dissemination of cancer cells during metastasis. 
Chemotaxis, directed migration towards soluble chemoattractants, is an important cue in 
mediating cancer cell migration towards the vasculature
38
.  The involvement of 
chemotaxis in metastasis is particularly well described for breast cancer, where intravital 
imaging has revealed that cells migrate along collagen fibers towards the vasculature in 
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response to gradients of epidermal growth factor (EGF)
164, 191, 192
. A second influential 
migration cue is contact inhibition of locomotion (CIL), discovered approximately 60 
years ago by Abercrombie and Heaysman in fibroblasts
193
. This phenomenon is described 
as the suppression of locomotion upon cell to cell contact and a subsequent redirection of 
motility. Interestingly, many malignant cells lack CIL with other cell types (heterotypic) 
but retain CIL with each other (homotypic)
51, 52, 194, 195
. These tendencies have been 
suggested to increase the invasiveness of cancer by preferentially directing cancer cells 
away from the primary tumor and into the stromal environment
52, 189, 194, 195
. The 
molecular basis of this preferential CIL response has recently been explored in prostate 
cancer cells
52
. Although chemotaxis and CIL have been recognized individually as 
important regulators of directed cell migration during metastasis, the interactions between 
these cues are still poorly understood. 
 Here we investigate the interplay between CIL and chemotaxis through the use of 
MTLn3 rat breast adenocarcinoma cells overexpressing the epidermal growth factor 
receptor (EGFR), referred to as MTLn3-B1
196
. These cells are highly metastatic
196
, 
exhibiting enhanced chemotaxis to EGF in vitro and in vivo and also display CIL
197
, as 
cell collisions redirect cells away from their original migration trajectories. To investigate 
the relationship between chemotaxis and CIL, we developed a series of new microfluidic 
devices allowing a controlled, direct comparison of these cues at the single cell level. We 
explore the molecular mediators of these cues in MTLn3 cells and find that chemotaxis 
and CIL do not act independently of each other. Modulation of the strength of chemotaxis 
signaling can alter the directed migration outcomes when both cues are present. We 
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suggest that this interplay enhances overall directed migration and may be applicable to 
many other systems. 
 
4.2  Results 
 
4.2.1  Development of a microfluidic device to explore CIL and 
chemotaxis 
  
 We developed a new microfluidic device to study the combined effects of CIL 
and chemotaxis on the directed migration of MTLn3-B1 cells in a high throughput 
manner. The device consists of a continually replenished source and sink connected by a 
parallel array of microchannels
133, 141
 (Fig. 4.1a, Fig. 4.2a-c). Gradients of EGF form 
across the microchannels via passive diffusion between the source and sink.  To ensure 
that gradients of EGF develop across all microchannels simultaneously, thus allowing an 
equal comparison of cell response kinetics, we surrounded the microchannels with an 
intermediate rounded zone, accessible to built in elastomeric valves from above (Fig. 
4.2c). Pressurizing the valves causes the rounded zones to collapse, effectively isolating 
the microchannels from the source and sink. In this manner, the source and sink can be 
pre-established at steady state around the microchannels without any transient 
stimulation, thus ensuring all microchannels receive the gradient coincidently when the 
valves are released (Fig. 4.2b-c). Gradients reach steady state in ~10 minutes and can be 
maintained for > 8 hours (Fig. 4.2b). We used device simulations to calculate the effect 











Fig. 4.1: MTln3-B1 chemotaxis in different EGF gradients and influences from CIL.  
 
(a) Schematic of the microfluidic device used to produce defined gradients of EGF across 
microchannels housing MTLn3-B1 cells. (b) Representative images of MTLn3-B1 cells 
undergoing chemotaxis in different EGF gradients. Green color visualizes expression of 
GFP. The gradient is visualized with a Dextran dye here and in subsequent images. Red 
asterisks track cell positions from time = 0.Times are in minutes. Scale bars, 20 m. (c-d) 
Quantification of velocity and chemotaxis index of MTLn3-B1 cells under control (0 ng/ml) 
and indicated EGF gradients from (b). Data is the mean from the number of indicated cells 
from n >= 3 independent experiments with error bars showing SEM. (e) An MTLn3-B1 cell 
displaying oscillations in migration in 65-85 ng/ml EGF gradients. (g-h) MTLn3-B1 cells 
undergoing CIL during chemotaxis. Colored asterisks track different cells. Yellow arrows 




gradient across the microchannels was 30% on the low side and 70% on the high side, in 










migrate in a single file, as the dimensions of the microchannels (14 m by 6 m, width 
by height) constrain cell migration to a single dimension. This fixation of one 
Fig. 4.2: Characterization of the microfluidic device used to study chemotaxis and 
CIL. 
 
(a) Schematic of the microfluidic device. Different colors represent different functional 
layers. The green fluidic layer is 130 m, the red rounded fluid layer is 30 m, and the 
yellow microchannel layer is 6 m. The blue layer is a valve layer (40 m) that controls 
fluid flow in the underlying red layer. (b) Enlarged view of the functional gradient 
generation area and quantification of gradient formation kinetics in the first 
microchannelchannel and last microchannel channel. Gradient formation begins 
simultaneously across all channels, becomes stables in ~10 minutes, and is stable over the 8 
hour experimental time period. (c) A side view illustrating the gradient formation strategy. 
(d-e) 3D computational fluid dynamics simulations of gradient generation in the 
microfluidic device. Quantification of the green line shown in the enlarged region is shown 
in (e). The concentration difference across the microchannels is 30-70%. 
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dimensional motility serves three purposes: 1) it optimizes the opportunities for CIL to 
occur, 2) it provides an unambiguous readout of cell collision outcomes based on the 
resulting direction of cell migration, and 3) it matches the motility of MTLn3-B1 cells in 
MTLn3-B1 derived primary tumors in vivo, where individual cells migrate along collagen 




4.2.2  Characterization of MTLn3-B1 chemotaxis 
 
 We first assessed how freely migrating MTLn3-B1 cells would respond to 
different gradients of EGF with a constant concentration difference (20 ng/ml) and varied 
mean concentrations (25 ng/ml, 50 ng/ml, and 75 ng/ml) (Fig. 4.1b). Upon introduction 
of EGF gradients, we observed the striking formation of large cell protrusions towards 
the source of EGF and rapid cell motility up the gradient (Fig. 4.1b). MTLn3-B1 cells 
displayed the highest velocity and greatest accuracy in 15-35 ng/ml EGF gradients, rarely 
changing directions and maintaining constant velocities (Fig. 4.1c-d). In contrast, 
MTLn3-B1 cells remained relatively stationary without a preferential direction in 
medium without EGF (Figure. 4.1c-d, Fig. 4.3a). Cell velocity and accuracy decreased 
with increasing mean concentration, but still retained a net preference up the gradient as 
compared to controls (Fig. 4.1b-d). In gradients with a high mean concentration of EGF 
(65- 85 ng/ml), many MTLn3-B1 cells displayed elongated cell morphologies and 
oscillatory migration patterns characterized by a frequent collapse of protrusions, 










concentration difference across channels, 30-70 ng/ml EGF) did not enhance chemotactic 
behavior beyond the optimal gradient found above (15-35 ng/ml EGF) (Fig. 4.3b-d ).  
 EGFR overexpression in MTLn3 cells has been previously associated with 
increased motility and chemotaxis in vitro and in vivo, along with enhanced metastatic 
potential
196
. Therefore, to validate our assay, we next investigated EGF chemotaxis in 
MTLn3 cells without EGFR overexpression (Fig. 4.3e, Fig. 4.4). MTLn3-B1 cells  
Fig. 4.3: MTLn3-B1 cells in control conditions and sharper EGF gradients.   
 
(a) MTLn3-B1 cells in microchannels without EGF. (b) MTLn3-B1 cells in 30-70 ng/ml 
EGF gradients. In a-b, green color denotes GFP expression, the blue color visualizes the 
gradient of EGF using dextran dye as a proxy, and red asterisks track cell positions. Times 
are in minutes. Scale bars, 20 m. (c-d) Quantification of the chemotaxis index (c) and 
velocity (d) of MTLn3-B1 cells in 30-70 ng/ml EGF gradients as compared to 15-35 ng/ml 
EGF gradients. 15-35 ng/ml EGFis reproduced from Fig. 4.1d-e.  Data represents the mean 
from the number of cells indicated from n = 3 independent experiments with error bars 
showing SEM. (e) Relative expression of EGFR mRNA in MTLn3-B1 cells vs. MTLn3 












expressed approximately 1.5 fold more EGFR transcripts than MTLn3 cells (Fig. 4.3e). 
Similar to MTLn3-B1 cells, MTLn3 cells displayed little motility and had unbiased 
Fig. 4.4: Characterization of chemotaxis and CIL in MTLn3 cells.  
 
(a) MTLn3 cells directionally migrating towards a 15-35 ng/ml gradient of EGF. (b) 
MTLn3 cells in microchannels without EGF. (c) MTLn3 cells chemotaxing to a 30-70 
ng/ml EGF gradient. In a-c, green color denotes GFP expression, the blue color visualizes 
the gradient of EGF using dextran dye as a proxy, and red asterisks track cell positions. 
Times are in minutes. Scale bars, 20 m. (d-e) Quantification of the chemotaxis index and 
velocity of MTLn3 cells in control and different EGF gradients. , data represents the mean 
from the number of cells indicated from n = 3 independent experiments with error bars 
showing SEM. (f-g) HH (f) and HT(g) collision outcomes in MTLn3 cells in uniform vs. a 
gradient of EGF at the indicated concentrations. Statistical comparisons are made between 
the same outcome in uniform vs. gradient. The asterisk denotes a statistically significant 
difference, p = .025, using a two sided student’s t-test. In (h-i), number of total cells are 
indicated and data represents the mean from n =3 independent experiments with error bars 
indicating SEM. * = p < .05.          
105 
 
migration in the absence of EGF (Fig. 4.4a). MTLn3 cells exhibited chemotaxis in 15-35 
ng/ml gradients of EGF, but had decreased velocities and accuracies as compared to 
MTLn3-B1 cells (Fig. 4.1c-d, Fig. 4.4b,d-e), in agreement with previous results
196
. In 
sharper EGF gradients (40 ng/ml concentration difference), MTLn3 cell accuracy did not 
improve but cell velocity increased (Fig. 4.4c-e).  Taken together, our results indicate that 
our device can efficiently assay chemotaxis in MTLn3 cells and can distinguish between 
MTLn3 cells with different metastatic potential.     
 
4.2.3  CIL alters chemotactic responses 
 
 Next, we focused on how CIL might affect the directional migration of MTLn3-
B1 cells during chemotaxis to chemical gradients of EGF. We found that CIL could 
dramatically influence chemotactic behavior by redirecting MTLn3-B1 cells either 
towards or away from the chemical gradient. This was especially prominent in groups of 
cells in single channels migrating at different velocities. For example, often times a “ping 
pong” pattern would emerge where a trailing cell would catch up to a leading cell and be 
redirected away, but would be subsequently reoriented back up the gradient by a second 
chemotaxing cell (Fig. 4.1g). Conversely, in some cases, CIL could abrogate chemotaxis. 
This is illustrated in Fig. 4.1h, where a cell is redirected back down the gradient and 
subsequently redirects another entering cell down the gradient, leading to the entire cell 
group moving away from the gradient (Fig. 4.1h). The phenotypes at the interface 
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between CIL and chemotaxis interactions (Fig. 4.1g-h) bring up several questions.  
Can one directed migration cue supersede the other? If so, under what circumstances does 
this occur? Are CIL and chemotaxis independent from each other? To answer these 
questions, we first sought to characterize the typical results of CIL without chemical 
gradients and to see how these results might shift in the presence of gradients.      
 
4.2.4  CIL in uniform concentrations of EGF 
 
 To decouple CIL from EGF chemotaxis, we stimulated MTLn3-B1 cells within 
microchannels with different uniform concentrations of EGF (25 ng/ml, 50 ng/ml, 75 
ng/ml), matching the mean concentrations of the previously imposed gradients. MTLn3-
B1 cells in the presence of uniform EGF displayed rapid changes in direction and 
frequent CIL events (Fig. 4.5a).  Cell to cell collisions could be categorized into two 
main groups (Fig. 4.5b), head to head collisions and head to tail collisions. In head to 
head (HH) collisions, two cells migrate towards each other, leading to the collapse of 
both protrusions upon contact (Fig. 4.5c). This collapse is subsequently followed by three 
different outcomes (Fig. 4.5c), both cells either migrate upwards (Outcome 1), in 
opposite directions (Outcome 2), or downwards (Outcome 3). In head to tail (HT) 
collisions (Fig. 4.5d), one cell (trailing) catches up to another cell (leading) migrating in 
the same direction.  Upon contact with the rear of the leading cell, two outcomes occur; 
the trailing cell either continues in the same direction (Outcome 1) or is repelled and 
migrates in the opposite direction (Outcome 2). In all cases, the leading cell remained 











protrusions. We found that regardless of the concentration of EGF, HH collisions 
typically lead to the repulsion of both cells in opposite directions (Outcome 2), 
Fig. 4.5: Characterizaton of CIL in uniform concentrations of EGF 
 
(a) MTLn3-B1 cells displaying random motility and undergoing multiple CIL events in a 
uniform concentration of EGF (50 ng/ml). (b) Schematic of the two categories of cell 
collisions leading to CIL. (c-d) Examples of the outcomes of head to head and head to tail 
collisions in MTLn3-B1 cells with corresponding illustrations. Collisions occur at time t = 
0. The blue asterisk tracks the top cell, while the red asterisk tracks the bottom cell. Yellow 
arrows indicate collisions. Times are in minutes. Scale bars, 10 m. (e-f)) Probability of 
head to head and head to tail collision outcomes in the indicated uniform concentrations of 
EGF. The total number of cells are indicated per condition. Data represesents the mean from 
n =3 independent experiments per condition and error bars show SEM. 
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suggesting a dose independent effect (Fig. 4.5e). Similarly, HT collisions primarily 
resulted in the repulsion of the follower cell (Outcome 2) in an EGF dose independent 
manner (Fig. 4.5f). MTLn3 cells also displayed similar propensities (Fig. 4.4f-g).  
 As CIL is traditionally studied in 2D formats, we also investigated whether 
MTLn3-B1 cells display CIL in 2D environments in various doses of EGF using a second 
microfluidic device with traditional CIL metrics (Fig. 4.6).  MTLn3-B1 cells exhibited 
CIL in 2D regardless of the dose of EGF (Fig. 4.6e), in agreement with our results above 
(Fig. 4.5e-f). We also observed that cell collisions selectively affected protrusions (Fig. 
4.6d). Our results suggest that CIL functions independent of the levels of uniform EGF 
signaling in 2D and 1D and specifically affects cell protrusions. To summarize, in 
uniform doses of EGF, HH collisions tend to result in the repulsion of both cells in 
opposite directions, while HT collisions repulse the follower cell. 
 
4.2.5  Chemotaxis biases CIL outcomes  
 
 Having characterized the outcomes of CIL in uniform doses of EGF, we next 
revisited how CIL outcomes were influenced by the presence of various gradients of EGF 
(Fig. 4.7a-c). Upon closer inspection, we found several HH collisions where the 
accurately migrating cell (bottom cell) did not lose its protrusion upon contact, as 
opposed to the inaccurately migrating cell, whose protrusion collapsed and reformed up 
the gradient (Fig. 4.7d). This result suggests that chemical gradients do not simply 
polarize cells after their protrusions collapse after contact. In 15-35 ng/ml EGF gradients, 











Fig. 4.6: CIL occurs in an EGF dose independent manner in 2D.  
 
(a) The schematic of the microfluidic device used to produce multiple doses of EGF in a 
single experiment. The green gradient generation and cell chamber layer is 100 m and the 
red rounded fluid layer is 30 m. The blue layer (40 m) is a control valve layer modulating 
flow in the red layer. (b) Sample image of different doses of EGF produced in the numbered 
cell chambers visualized with a dextran dye. (c) Quantification of mean fluorescence 
intensity in the labeled cell chambers in (b), showing the different doses produced. (d) 
MTLn3-B1 cells undergoing head to head (HH) (top panel) or head to tail (HT) (middle 
panel) collisions as opposed to free movement (F) (bottom panel). Corresponding metrics 
used to analyze them are shown on the side. The vector, Cx, represents the change in 
acceleration due to either a collision or random migration. Cx is normalized to account for 
differences in velocity. Green color indicates GFP expression. Colored asterisks track 
individual cells. Times are in minutes. Scale bars, 20 m. (e) Quantification of Cx in HH 
and HT collisions vs. free moving cells (F) in different doses of EGF. . n > = 15 cells from 3 
independent experiments per condition. ** = p <1e-3 from a student’s t-test. 
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significant shift in HH collisions towards outcome 1 (migration of both cells up the 











Fig. 4.7: Chemotaxis biases CIL towards gradients  
 
(a) Schematic of how chemotaxis and CIL cues conflict during different cell collisions. (b-
c) Examples of the outcomes of head to head (b) and head to tail (c) collisions in MTLn3-
B1 cells in gradients of EGF with corresponding illustrations. Collisions occur at time t = 0. 
Green color indicates expression of GFP. The gradient of EGF is visualized with Dextran 
dye here and in all subsequent images. Colored asterisks track different cells. Yellow arrows 
indicate collisions.  (d) A head to head collision between MTLn3-B1 cells where the bottom 
cell maintains its protrusion. Yelllow arrow indicates the collision. (e-g) Probabilities of 
head to head collision outcomes in gradients of EGF vs. uniform concentrations. Uniform 
concentrations are taken from Fig 4.5e. Number of collisions analyzed is indicated. Data 
shown is the mean of n = 3 independent experiments with error bars representing SEM. 
Statistical comparisons are made between the same outcome in uniform vs. gradient using a 
student’s t-test.  (h) A group of MTLn3-B1 cells streaming up a gradient of EGF. Red 
asterisks track cell positions. (i-k) Probabilities of head to tail collision outcomes in 
gradients of EGF vs. uniform concentrations. Uniform concentrations are taken from Fig. 
4.5f. Total colllisions analyzed per condition are displayed. Data is the mean of n = 3 
independent experiments per condition. Error bars are SEM. Statistical comparisons are 
made between the same outcome in uniform vs. gradient using a student’s t-test.  Times are 
in minutes. Scale bars, 10 m. * = p < 1e-3. 
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chemotaxis can influence CIL behavior.  This shift was diminished but still significant in 
40-60 ng/ml EGF gradients as compared to a uniform 50 ng/ml EGF dose (Fig. 4.7f), but 
was completely lost in the 65-85 ng/ml EGF gradient (Fig. 4.7f), where the collision 
outcomes mirrored those of the uniform 75 ng/ml EGF dose (Fig. 4.7f). HH collisions in 
MTLn3 cells chemotaxing in 15-35 ng/ml EGF gradients also became biased towards 
outcome 1 (Fig. 4.6f), albeit with a smaller shift than MTLn3-B1 cells (Fig. 4.7e), 
suggesting that EGFR overexpression increases the influence of chemotaxis over CIL. 
Overall, our results suggest that modulating the strength of chemotactic behavior, either 
by altering external gradient inputs or changing receptor expression, can dynamically 
alter the balance between chemotaxis and CIL cues.    
 Next, we tracked the outcomes of MTLn3-B1 HT collisions in gradients of EGF 
(Fig. 4.7b). We found many MTLn3-B1 cells streaming together in close apposition (Fig. 
4.7h), as has been observed in MTLn3 derived tumors in vivo
196
. This suggested that HT 
collision induced CIL may be reduced in optimal EGF gradients.  In 15-35 ng/ml EGF 
gradients, we indeed found a significant shift in HT collisions towards outcome 1 
(Trailing cell maintains its protrusion and continues migrating up the gradient) as 
compared to the 25 ng/ml uniform EGF control (Fig. 4.7i), providing further evidence 
that chemotaxis influences CIL. As seen in HH collisions, we saw a similar but 
diminished shift in 40-60 ng/ml EGF gradients as compared to the 50 ng/ml uniform EGF 
controls (Fig. 4.7j), and total loss of the shift in 65-85 ng/ml EGF gradients, where the 
outcomes effectively mimicked those of the 75 ng/ml uniform EGF control (Fig. 4.7k). 
The outcomes of HT collisions in MTLn3 cells migrating in 15-35 ng/ml EGF gradients 
were slightly shifted from uniform 25 ng/ml EGF controls (Fig. 4.6g). 
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 Thus far we have shown that chemotaxis and CIL are both cues which can 
substantially influence directed migration in MTLn3 cells. Furthermore, we have shown 
that they are not independent from each other when both are present, suggesting that the 
chemotaxis and CIL signaling pathways dynamically regulate each other. The molecular 
components which mediate CIL and chemotaxis in MTLn3 cells are still poorly 
understood. It is also unknown where crosstalk might occur between these two pathways. 
Therefore we next set out to identify molecular components of the chemotaxis and CIL 
pathways in MTLn3 cells. 
 
4.2.6    PI3K and Rac activity during chemotaxis and CIL 
  
 First, we investigated molecules activated during MTLn3-B1 chemotaxis. 
Phosphatidylinositol 3-kinase (PI3K) and Rac are well known regulators of directed 
migration and have been shown to be at active the leading edge of several chemotaxing 






. Their roles in 
EGF stimulated protrusion formation have been investigated in MTLn3 cells
200, 201
, but 
their localization and activity in living MTLn3 cells during chemotaxis are unknown. 
Therefore, we transfected MTLn3-B1 cells with PI3K and Rac biosensors and observed 
their responses during EGF chemotaxis in our microfluidic device. To observe PI3K 
activity, we used the ph domain of Akt (Akt-ph) tagged with a mCherry fluorophore 
(mCH-Akt-ph) (Fig. 4.8a) and took its ratio to a cytosolic GFP to remove volume effects, 
as has been done previously
150
. PI3k activity in MTLn3-B1 cells became locally enriched 














Fig. 4.8: PI3K, Rac, and F-actin are active at the leading edge during chemotaxis and 
are inhibited by CIL 
 
 (a) Representative images of PI3K activity during MTLn3-B1 chemotaxis to EGF (15-35 
ng/ml). The pseudcolor images in the top panel represent the ratio between Mch-Akt-ph and 
GFP. Green color in the middle panel visualize GFP expression. Red color in the bottom panel 
displays Mch-Akt-ph. (b) Quantification of the polarity ratio in chemotaxing mCh-Akt-ph 
expressing MTLn3-B1 cells vs. control mCh expressing cells. Data represents the mean of n >= 
20 cells per condition from n = 3 independent experiments. Error bars are SEM. (c) 
Representative images of Rac activity during MTLn3-B1 chemotaxis to EGF (15-35 ng/ml). 
Pseudocolor images show the FRET ratio (YFP FRET/CFP) from the Raichu-Rac construct. (d) 
Quantification of the FRET polarity ratio in MTLn3-B1 cells with and without a gradient of 
EGF. Data represesents the mean from n >= 12 cells from n = 3 independent experiments. Error 
bars show SEM. (e) Representative images of the localization of F-actin during MTLn3-B1 
chemotaxis to EGF (15-35ng/ml). Green color in the top panel indicates expression of GFP. 
Red color in the bottom panel displays Lifeact-RFP. Yellow arrows highlight localized 










 (Fig. 4.8b). Conversely, a control mCherry construct without a ph domain did not show 








Cont- (f-g) Visualization of (f) PI3K activity and (g) Rac activity during CIL.. Collisions 
occur at time t = 0. The top series of images illustrate colliding cells while the bottom series 
illustrates free moving cells. The first image in each of the top series of images visualizes the 
collision, showing the tracked cell outlined in red and the cell it is colliding with in blue. 
These outlines are reproduced in the ratio image at time = 0. Pseudocolor images represent 
the ratio between Mch-Akt-ph and GFP in (f) and the FRET ratio (YFP FRET/CFP) in (g). 
(h-i) Quantification of the polarity ratio in colliding cells and free moving cells for (h) PI3K 
and (i) Rac. Free moving cells retain a constant polarity while colliding cells exhibit a 
decrease after the collision. Data represents the mean  from n >= 11 cells per condition from 
3 independent experiments with error bars representing SEM. Times are in minutes. Scale 
bars, 10 m. 
Fig. 4.9: PI3K and Rac activity controls.  
 
(a) A representative time series of a MTLn3-B1 cell expressing  GFP and Mcherry 
chemotaxing to a gradient of EGF (15-35 ng/ml). The pseudocolor in the top series of images 
represents the ratio between Mcherry and GFP. Green color denotes GFP expression, red color 
denotes Mch expression, and the blue color visualizes the EGF gradient via a dextran dye. 
Quantification of control data is found in Fig. 3b. (b) Representative time series of a MTLn3-
B1 cell expressing a Raichu-Rac FRET sensor in a microchannel without EGF. Cells do not 
polarize and remain stationary. The pseudocolor represents the FRET ratio (YFP FRET/CFP). 




observe Rac activity during MTLn3-B1 EGF chemotaxis (Fig. 4.8c). Similar to PI3K, 
Rac also became locally activated at the cell front in EGF gradients (Fig. 4.8c), but with 
slower kinetics (Fig. 4.8d). Without EGF, Rac FRET activity remained unpolarized (Fig 
4.8d, Fig. 4.9b).  We also looked at the localization of F-actin during MTLn3-B1 
chemotaxis, as Cofillin, an actin severing protein, has been shown to be important for 
directional migration in MTLn3 cells
202
.  Using a mCherry tagged Lifeact sensor to detect 
F-actin, we observed F-actin spikes localized to the front of chemotaxing MTLn3-B1 
cells (Fig. 4.8e), suggesting that in our assay, chemotaxing MTLn3-b1 cells migrate with 
F-actin mediated protrusions. Overall, our results indicate that the activity PI3K, Rac, and 
F-actin are polarized towards the front of MTLn3-B1 cells during EGF chemotaxis. 
 We next assessed if PI3K and Rac were regulated by CIL by tracking their 
activity during cell collisions (Fig. 4.8f-g). As a control, we compared their activity 
during collisions to freely chemotaxing MTln3-B1 cells (Fig. 4.8f-g). Freely 
chemotaxing MTLn3-b1 cells maintain constant PI3K and Rac activity at the cell front 
(Fig. 4.8f-i). Conversely, cell collisions induce a local downregulation of both PI3K and 
Rac at the leading edge of MTLn3-B1 cells as protrusions collapse (Fig. 4.8f-i). When 
contacting MTLn3-B1 cells repolarize and migrate in the opposite direction, PI3K and 
Rac relocalize to the new protrusion, leading to a decrease in the polarity ratio (Fig. 4.8h-
i). Taken together, these results suggest that PI3K and Rac may be targets of regulation 
by CIL.     
 




 Next, we sought to identify the molecular components which induce CIL in 
MTLn3-B1 cells. As the upstream mediators of CIL in MTLn3-B1 cells are unknown, we 
set up a series of obstacles to assess their ability to induce CIL during chemotaxis to EGF 
(Fig. 4.10a).  We first investigated two mechanical barriers by seeding either 3T3 
fibroblasts or 5 m diameter protein A coated silica beads directly into microchannels 
and inducing MTLn3-B1 chemotaxis towards them (Fig. 4.10a). Although 3T3 cells 
encompassed most of the microchannel, we surprising found that the majority of 
chemotaxing MTLn3-b1 cells could migrate around and actively displace them (9/10 
collisions result in migration past 3T3 cells) (Fig. 4.10b). This result suggests two ideas- 
first, that signaling plays a prominent role in inducing CIL, as the mechanical properties 
of 3T3s should be roughly similar to those of MTLn3-B1 cells, and second, that MTLn3-
B1 display reduced heterotypic CIL, which has been noted in other cancer cells
52, 203
 and 
is thought to increase malignancy. Next, we studied collisions between chemotaxing 
MTLn3-B1 cells and protein A coated silica beads. Single protein A coated silica beads 
only took up roughly 1/3 of the width of a microchannel, nonetheless, the resulting 
MTLn3-B1 bead collisions did induce some repulsion events (Fig. 4.10c-d), indicating 
that there may be some mechanical contributions to MTLn3-B1 CIL.   The majority of 
collisions, however, did not affect chemotaxing MTLn3-B1 cells (Fig. 4.10d), suggesting 
again that signaling predominantly mediates CIL in MTLn3-B1 cells.   
 Protein A coated silica beads can be functionalized with fc tagged proteins and 
can be used to screen for proteins which induce CIL. We therefore screened a set of fc 
tagged proteins known to mediate CIL in other cell systems and assessed their ability to 













Fig. 4.10: Eph B signaling is sufficient to induce CIL in MTLn3-B1 cells 
 
 (a) Schematic of the different obstacles assessed for their ability to induce CIL in chemotaxing 
cells (15-35 ng/ml EGF gradients). (b) Selected images of a MTLn3-B1 cell colliding and 
migrating around a 3T3 cell during chemotaxis. Green color indicates expression of GFP and 
identifies the MTLn3-B1 cell.  (c) Representative images of cells undergoing repulsion (top 
panel) or being unaffected (bottom banel) by protein A coated silica beads during chemotaxis. 
Red dashed lines highlight the boundaries of cells shown in green. Blue dashed lines outline 
silica beads. Times are in minutes. Scale bars, 10 m. (d) Quantification of the results of 
MTLn3-B1 bead collision events during chemotaxis with different silica bead coatings. 
Number to total collisions analyzed per condition is indicated from n >= 2 independent 
experiments. (e) Visualization of the binding of ephrin-b1-fc or fc to cells by immunostaining 
against the fc domain (shown in green). Nuclei are denoted in blue with A summary table is 
shown on the right for all tested ephrin-fc ligands. Scale bars, 50 mm. (f) Relative expression of 
ephrin b ligand and Eph B receptors  in MTLn3-B1 cells from real time RT-PCR. Data 
represents the mean from n = 3 biological replicates. Error bars are SD. (g) Selected images of 
MTLn3-B1 cells stimulated with EGF and then treated with either clustered ephrin b1-fc (Top 
panel) or fc (Bottom panel). Green color indicates expression of GFP. Times are in minutes. 
Scale bars, 20 m. (h) Cell area after indicated treatments in g. Data is the mean from n >= 90 
cells per condition from n = 3 independent experiments. Error bars are SEM. 
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the ability of the fc domain itself to induce CIL.  Fc domain coated beads induced cell 
repulsion with an equal probability to that of uncoated protein A beads, indicating that 
the fc domain itself did not provide any signaling (Fig. 4.10d). Next, we tested E-





. E-cadherin is known to be upregulated in metastatic MTLn3 cells as 
compared to nonmetastatic variant MTC cells
191
 and could be detected with 
immunostaining (Fig. 4.11a). Our results indicated that E-cadherin-fc coated silica beads 
did not significantly increase the chance of repulsion of chemotaxing MTLn3-B1 cells 
(Fig. 4.10d). Therefore, we next looked to the Eph receptor systems, which are 
responsible for CIL in a variety of systems, such as axon guidance
188, 205
,  prostate cancer 
cells
52
, and endothelial cells
206
.  
 The Eph receptors are the largest family of receptor tyrosine kinases
207
 (RTKs) 
and can be split into A and B families based on their affinity for 
glycosylphospatidylinositol (GPI) linked ephrin a  or transmembrane ephrin b ligands
208
. 
To test the ability of Eph receptor and ephrin ligand interactions to induce CIL in 
chemotaxing MTLn3-B1 cells, we functionalized beads with either ephrin b1-fc or ephrin 
a1-fc, which can promiscuously bind Eph B and Eph A receptors
209
, respectively. Ephrin 
b1-fc, but not ephrin a1-fc, coated beads increased the probability of contact repulsion 
with MTLn3-B1 cells, suggesting that activation of Eph B receptors via ephrin ligands is 
sufficient to induce CIL in these cells (Fig. 4.10d). We verified the presence of Eph B 
receptors on MTLn3-B1 cells by incubating live MTLn3-B1 cells with various 
unclustered soluble ephrin b-fc ligands and immunostaining without permeabilization 
against the fc domain at 4
◦





Incubation with the fc domain itself did not produce any signal, indicating that the 
binding of the ephrin b ligands was specific to their substrates, the Eph B receptors (Fig. 
4.10e). We also verified that MTLn3-B1 cells express Eph A receptors by incubation and 
subsequent immunostaining with various ephrin a-fc ligands (Fig. 4.11c). Ephrin-fc 
ligand binding results are summarized in Fig. 4.10e.  Finally, we performed real time RT-
PCR in MTLn3-B1 cells to verify the expression of various ephrin b and Eph B 
transcripts (Fig. 4.10f). Ephrin b2 was the predominant ephrin b isoform, however, it 
Fig. 4.11: Immunostaining of E-cadherin 
and the binding of various ephrins.  
 
(a) Representative images of E-cadherin 
immunostaining shown in red with and 
without a blocking peptide in MTLn3-B1 
cells. Hoechst 33342 staining shown in blue 
denotes nuclei. (b-c) Representative images 
of the binding of the indicated ephrin 
proteins to MTLn3-B1 cells shown in green 
by immunostaining against the fc domain. 
Hoechst 33342 staining in blue denotes 
nuclei. Scale bars, 50 m. 
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retained similar cell surface binding to ephrin b1 (Fig. 4.10e, Fig. 4.11b), suggesting that 
both ephrin b ligands bind Eph B receptors on MTLn3-B1 cells with similar affinity.   
Overall, our results demonstrate that MTLn3-B1 cells express both ephrin b ligands and 
Eph B receptors and thus possess the necessary components to induce homotypic CIL.  
 To clarify the functional effects of Eph B signaling, we tested whether soluble, 
clustered ephrin-b1 fc could produce functional retraction in EGF stimulated MTLn3-B1 
cells. We performed live cell imaging experiments where we first added EGF to MTLn3-
B1 cells to induce protrusion formation and then subsequently added either clustered 
ephrin b1-fc or clustered fc (Fig. 4.10g). Clustered ephrin-b1-fc induced significant cell 
retraction while fc treatment had no effect (Fig. 4.10h), suggesting that Eph B signaling 
is functionally sufficient to suppress protrusions in EGF stimulated MTLn3-B1 cells. 
 
4.2.8  Crosstalk between chemotaxis and CIL occurs above PI3K 
 
 After identifying Eph B signaling as an upstream mediator of CIL in MTLn3-B1 
cells, we next sought to identify what components downstream of Eph B interact with the 
chemotaxis pathway. One molecule likely to be downstream of Eph B is RhoA, a 
member of the small Rho GTPases previously shown to be a mediator of contact 
repulsion in growth cones, neural crest cells, and prostate cancer cells. RhoA is also 
known to have an antagonistic relationship with Rac, and therefore could potentially 
inhibit chemotaxis through Rac. To observe RhoA activity during either EGF or clustered 
ephrin b1-fc treatment, we used a Dora-Rho FRET construct (Fig. 4.12). Surprisingly, we 









(Fig. 4.12a-d). A point mutated, control Dora RhoA construct did not show an increase 
with EGF stimulation (Fig. 4.12b). These results suggest that RhoA is not downstream of 
Eph B receptors in MTLn3-B1 cells. The addition of EGF lead to protrusion formation 
and similar increases in cell area in MTLn3-B1 cells endowed with either FRET 
construct (Fig. 4.12e). However, application of ephrin b1-fc did not induce cell retraction 
(Fig. 4.12e). This was in stark contrast to the MTLn3-B1 cell retraction observed after 
Fig. 4.12: RhoA is not activated by Eph B signaling.  
 
(a-b) Representative images of RhoA activity from Dora-RhoA FRET(a) or control Dora-Rhoa 
FRET(b) constructs in MTLn3-B1 cells during EGF stimulation. (c) Representative images of 
RhoA activity from a Dora-Rhoa FRET construct in MTLn3-B1 cells during ephrin b1-fc 
stimulation. Times are in minutes. Scale bars, 20 m. (d-e) Quantification of the FRET ratio (d) 
and cell area (e) in the conditions specified above. Data indicates the mean from n >= 26 cells 
per condition from n = 3 independent experiments with error bars representing SEM. 
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the addition ephrin b1-fc in the context of EGF stimulation (Fig. 4.10g-h), suggesting 
that Eph B signaling in MTLn3-B1 cells may function by suppressing components 
activated by EGF signaling without actively signaling to contractile machinery.  To test 
this idea, we pretreated MTLn3-B1 cells with clustered ephrin b1-fc before adding EGF 
(Fig. 4.13a). We hypothesized that if Eph B signaling mobilizes inhibitory machinery, 
then EGF mediated cell spreading would be diminished. Indeed, we found that 
pretreatment with ephrin b1-fc attenuated EGF induced cell spreading (Fig. 4.13a-b), 
suggesting that Eph B signaling induces CIL by suppressing EGFR signaling.    
 We next sought to identify which components downstream of EGFR were 
inhibited by Eph B signaling. Earlier, we showed that PI3K was activated in gradients of 
EGF and was inhibited by cell contact. Therefore, PI3K could potentially be inhibited by 
Eph B signaling. To assess the possible regulation of PI3K by Eph B signaling, we used 
chemically induced heterodimerization (CID) technologies to directly activate  PI3K by 
translocating its activator to the plasma membrane after ephrin b1-fc pretreatment 
(Supplementary Fig. S8c-d). We did not find any significant differences in cell spreading 
after direct activation of PI3K with and without ephrin b1-fc pretreatment 
(Supplementary Fig. S8c-d), suggesting that Eph B mediated inhibition of EGFR 
signaling occurs between PI3K and EGFR. To confirm this, we performed similar 
experiments for Rac (Supplementary Fig. 8e-f), generally agreed to be downstream of 
PI3K, and found that ephrin-b1 pretreatment did not affect Rac mediated cell spreading. 
Taken together, these results suggest that Eph B signaling inhibits EGFR signaling 














Fig. 4.13: Eph B inhibition of EGFR signaling occurs upstream of PI3K.  
 
In all conditions, MTLn3-B1 cells are pretreated with either clustered ephrin b1-fc or fc for 45 
minutes before the addition of either EGF or rapamycin. (a) Representative images of MTLn3-
B1 cells responding to EGF with either ephrin b1-fc or fc pretreatment. Red outlines trace cell 
boundaries. Times are in minutes. Scale bars, 20 m. (b) Quantification of cell area after EGF 
stimulation from (a). Data is the mean from n >= 80 cells per conditions from n = 3 
independent experiments with error bars being SEM. (c,e) Representative images of direct (c) 
PI3K or (e) Rac activation after the addtion of 100 nm rapamycin with either ephrin b1-fc or fc 
pretreatment. Red outlines trace cell area.  Times are in minutes. Scale bars, 20 m. (d,f) 
Quantification of cell area after activation of PI3K(d) or Rac (f) with 100 nm rapamycin after 
indicated pretreatments. Data indicates the mean from n >= 40 cells per condition from n = 3 
independent experiments with error bars representing SEM. 
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4.3  Discussion 
 
 We have developed a new set of devices to individually and collectively address 
chemotaxis and CIL in single breast cancer cells in a high throughput and well controlled 
manner. These devices allow the real time observation of MTLn3 chemotaxis in different 
gradients of EGF and how CIL affects these processes. We compare CIL in uniform vs. 
gradients of EGF and make the striking observation that chemotaxis and CIL do not act 
independently when both cues are present. This is demonstrated by our findings that 
tuning the strength of chemotaxis signaling can alter the balance between these two cues 
(Fig. 4.14a). Overexpression of EGFR and optimal EGF gradients increase the influence 
of chemotaxis over CIL, as evidenced by the shift in collision outcomes towards the 
gradient. Conversely, suboptimal EGF gradients, which elicit weaker chemotactic 
responses, do not produce any shifts.     
 We further identify molecular components involved in chemotaxis and CIL in 
MTLn3 cells and identify where these respective pathways might crosstalk.  During 
chemotaxis, MTLn3 cells respond to gradients of EGF by activating PI3K, Rac, and F-
actin at the leading edge (Fig. 4.14a). PI3K and Rac retain persistent activity at the 
leading protrusion in freely chemotaxing MTLn3 cells and are inhibited by CIL. We find 
that CIL in MTLn3 can be mediated through Eph B signaling (Fig. 4.14a), as evidenced 
by the increased probability of cell repulsion with ephrin b1 coated beads and cell 
retraction induced by the addition of exogenous ephrin b1 ligands. Crosstalk between 











 Where might EphB signaling inhibit EGF signaling between EGFR and PI3K to 
induce the collapse of protrusions? We found that one of the likely candidates, RhoA, 
Fig. 4.14: Interplay between CIL and chemotaxis optimizes cell dispersion.  
 
(a) CIL presents an efficient search strategy by preferentially directing cells away from cell 
clusters to explore new space. This cell dispersal enhances the probability of finding chemical 
gradients to initiate chemotaxis. Chemotaxis is an efficient mechansism to direct cell motility to 
specific locations. (b) The interplay between CIL and chemotaxis is mediated in MTLn3 cells 
by regulation of EGF (chemotaxis) and EphB/ephrin b (CIL) signaling. Various conditions can 
shift the balance from one pathway to the other, resulting in the preferential redirection of 
collding cells.            
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was not activated in MTLn3 cells in response to EphB signaling (Fig. 4.12). Moreover, 
we found that induction of EphB signaling without prior EGF signaling did not induce 
cell retraction, suggesting a mechanism of regulation where contractile machinery is not 
activated by Eph B. We propose, instead, that in MTln3 cells, Eph B signaling induces 
the collapse of cellular protrusions by directly inhibiting EGF signaling or other factors 
which induce migration. Therefore, we suggest two possibilities based on the current 
understanding of Eph signaling. One possible mechanism is through R-Ras, a member of 
the Ras family of small GTPases
210
.  R-Ras can activate PI3k
210, 211
 and has been shown 
to be inactivated by Eph receptors
209
.  Another possible mechanism is through 
endocytosis of EGFR receptors. Previous groups have shown that in cells which 
demonstrate CIL through Eph B signaling, EphB receptors and ephrin b ligands are trans-
endocytosed when cells collide
212, 213
, serving as a mechanism for downregulation of Eph 
receptor signaling. Co-endocytosis of EGFR during these trans-endocytosis events may 
mediate inhibition of EGF signaling.       
  A prominent system where the contributions of chemotaxis and CIL during 
directional migration have been investigated are in neural crest cells
190
. Neural crest cells 
migrate as a cell cluster with transient cellular interactions. CIL between neural crest cells 
is mediated through N-cadherin which activates RhoA, which then antagonizes Rac, 
leading to the collapse of cellular protrusions
214
. During collective neural crest migration, 
CIL directs protrusions away from the cell cluster and gradients of SDF-1 in turn serve to 
stabilize these protrusions to generate productive directed migration
190
. The gradients of 
SDF-1 themselves are not sufficient to induce a directed response without CIL, as 





Conversely, we show here that in MTLn3 cells, where directional migration occurs 
primarily on a single cell basis along collagen fibers
196
, chemotaxis to EGF serves as the 
main driving for inducing directed migration. In some aspects, CIL is a secondary factor, 
as directed migration can still occur efficiently in the absence of CIL. We also find that 
CIL mediated inhibition of cell protrusions does not occur through RhoA, but through 
inhibition of upstream EGFR signaling.  
 In the context of metastasis, we suggest that being responsive to both CIL and 
chemotaxis is an optimized strategy for cell dispersion, as each cue imparts its own 
distinct advantages (Fig. 4.14b). Acquisition of homotypic CIL is an effective search 
strategy which directs cells away from the cell population, maximizes the exploration 
space, and can occur in the absence of an external stimulus (Fig. 4.14b). For example, 
CIL is sufficient to spread out initially clustered cell populations and drive the uniform 




. This in turn increases the 
probability of finding sources of chemical gradients from exit targets, such as blood 
vessels or lymph nodes (Fig. 4.14b). Once these chemical gradients are detected, 
chemotaxis serves as a potent cue in eliciting a strong directional migration response. 
 However, being responsive to both CIL and chemotaxis could have potential 
drawbacks. For example, cells collisions between chemotaxing cells could redirect cells 
away from their intended targets and reduce overall chemotactic efficiency. Our results 
demonstrate that CIL outcomes shift in the presence of chemical gradients and thus 
provide a mechanism to mitigate these drawbacks. In optimal chemical gradients, HH 
collisions outcomes are biased towards both cells moving up the gradient. This switch in 
behavior allows inaccurate cells to be repolarized back up the chemical gradient by 
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trailing cells, thus preserving the fidelity of the original intended direction. Furthermore, 
we find that in optimal chemical gradients, HT collision induced CIL is suppressed. 
Therefore, collision induced repulsion between streaming cell populations during 
chemotaxis would be repressed.   
 Overall, we show here how multiple guidance cues can be interpreted at a single 
cell level and how the resulting interactions can produce beneficial phenotypes. We 
suggest that multiple guidance cues act in a dependent manner, that is dynamic and 
context dependent.           
 
4.4  Materials and Methods 
 
4.4.1  Cell culture and reagents 
 
 MTLn3 GFP, MTLn3-B1 GFP, and MTLn3-B1 cells were a gift from J. Segall 
(Albert Einstein, NY).  MTLn3 GFP, MTLn3-B1 GFP, and MTLn-B1 cells were 
maintained in Cellgro) with 5% FBS (Gibco) and 1% penicillin/streptomycin 
(Sigma). 3T3 cells were cultured in DMEM (Cellgro) with 10% FBS (Gibco) and 1% 
penicillin/streptomycin. All cell lines were cultured in a humidified 37 
◦
C and 5% CO2 
incubator.  EGF and Rat tail collagen 1 were obtained from Invitrogen. Ephrin-fc ligands 




 The following primary antibody was used- monoclonal Rabbit anti-E-Cadherin 
(Cell Signaling). The following secondary antibodies were used- Goat anti human IgG Fc 
(Jackson Labs), FITC conjugated Goat anti human IgG Fc (Millipore), and Alexa Fluor 
594 Goat anti rabbit IgG (Invitrogen).   
 Transfections were carried out using Fugene HD (Promega) according to 
manufacturers recommendation. MTLn3-B1 cells without GFP expression were used for 
all FRET experiments. The Raichu-Rac FRET construct was a gift from M. Matsuda 
(Tokyo University, Japan), while the Dora-RhoA FRET constructs were a gift from Y. 
Wu (UCHC, CT). 
 
4.4.2  Device fabrication  
 
 Microfluidic devices were fabricated using a traditional two layer soft lithography 
process
116
 out of polydimethylsiloxane (PDMS) from Momentive by replica molding off 
of silicon wafer masters. Silicon masters were created using standard photolithography 
techniques
90
. Device designs were created in Freehand MX (Macromedia) and AutoCAD 
(Autodesk). 
 
4.4.3  Device protocol 
 
 Microfluidic devices were prepared by cleaning with 70% ethanol and an alconox 
solution. Devices were then bonded to 22 x 40 mm #1 coverglass (Fisher) and incubated 
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in an oven set at 80
◦
C overnight. Before experiments, devices control valves were first 
filled with DI water by pressurizing with 10 PSI using solenoid valves (The Lee 
company). Subsequently, valves “5” and “7” (Shown in blue, Supplementary Fig. S1a) 
were pressurized to restrict fluid flow to the gradient generation region and a 40 g/ml 
collagen 1 solution was introduced into one of the two “c” ports (Shown in green, 
Supplementary Fig. S1a) in order to fill the source, sink, and microchannel region. 
Devices were coated with collagen for 1 hour before the collagen solution was exchanged 
for cell medium.   Cells were seeded as follows- Cells were trypsinized and resuspended 
in normal cell culture medium at a concentration of 10 million cells/ml. The cell 
suspension was then pipetted onto one of the “c” ports and induced in to the 
microchannel region by gravity flow. To terminate cell seeding, the valve opposite to 
where cells were introduced  was pressurized (either valve “6” or valve “8”) and the 
pressure in valve “5” was released to allow extraneous cells to be removed from the 
source and sink channels via flow from the inlet labeled “w” (shown in red, 
Supplementary figure S1a). Cells were allowed to adhere for 4 hours before 
experimentation. Typical experiments were run with cell medium solution in the sink side 
of the device and an EGF containing solution in the source side. Input solutions were 
introduced from the inlet network labeled “1-4” (Shown in green, Supplementary Fig. 
S1a). During the establishment of the source and sink, cells in the microchannel region 
were isolated by pressurizing valves “8” and “6” (Supplementary Fig. S1c). Finally, 
experiments were initiated when these valves were released and gradients of EGF were 
allowed to form across the microchannels via diffusion between the pre-established 





4.4.4  Imaging 
 
 Live cell imaging experiments were performed on a Zeiss Axiovert 200M 
epifluorescence microscope with a motorized stage (Prior) in an environmental chamber 
set at 37 
◦
C and 5% CO2  with a 40x, 1.3 numerical aperture oil immersion objective 
(Zeiss) coupled to a Cascade II:1024 EMCCD camera (Photometrics). Slidebook 
software (Intelligent Imaging Innovations) was used for automated control of the 
microscope system.  
 Immunostained samples were imaged on a confocal Zeiss LSM510-Meta using a 
63x Planapo oil objective driven by Zen software (Zeiss).  
 
4.4.5  Live cell imaging experiments      
 
 MTLn3 cells were seeded onto 25 mm glass coverslips (Fisher) coated with 40 
g/ml Rat Tail Collagen 1 (Invitrogen) for 1 hour at room temperature. Cells were 
allowed to attach overnight and then were subsequently starved for 3 hours in L15 
medium with .35% BSA (Invitrogen). The glass coverslip was then transferred to 
Attofluor live cell imaging chambers (Invitrogen), mounted onto the microscope, and 
stimulated with 100 ng/ml EGF (Invitrogen) or1 g/ml preclustered ephrin b1-fc (R&D 
systems). Ephrin b1-fc was preclustered at at 1:10 ratio with Goat anti-human Fc  for 1 
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hour at 37 
◦
C. In some experiments, EGF treatment was followed by the addition of 1 
g/ml preclustered ephrin b1-fc or 1 g/ml preclustered fc. For chemically induced 
heterodimerization experiments, 100 nM of rapamycin was added. 
 
4.4.6  Image Analysis and metrics 
 
 Image analysis was carried out using custom scripts written in Matlab 2007b 
(Mathworks). All images were first flatfield and darkfield corrected using the following 
routine- C = (I-D/F-D)*M where C = corrected image, I = initial image, D = darkfield 
image, F = flatfield image, and M = mean of difference between flatfield and darkfield 
images. Flatfield and darkfield images were obtained by averaging multiple images. 
Images were then Gaussian filtered to remove noise.  
 To analyze cell velocity and the chemotaxis index (CI), cells were semi-
automatically segmented by thresholding from GFP images and position data was 
generated by obtaining the centroid of segmented cells. Only cells which did not come 
into contact with other cells were used in this analysis. The chemotaxis index is defined 
as the distance moved up the gradient divided by the total distance traveled. Positive 
values were given to migration up the gradient, while negative values were given to 
migration in the opposite direction.  
 To analyze mCherry-Akt-ph biosensor data, cell images were background 
subtracted and then segmented by thresholding from GFP images to create a binary mask. 
This mask was then multiplied into both the original mCherry image and the GFP image 
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to isolate the fluorescence data of a single cell. The single cell mCherry image was then 
divided by the single cell GFP image to obtain the ratio.  
 To analyze FRET data (Raichu-Rac, Dora-RhoA), we followed a previously 
described protocol
181
. Brielfy, CFP and YFP FRET images (CFP excitation, YFP 
emission) were background subtracted, thresholded based on intensity, and aligned with a 
dft registration algorithm. The final ratio images were obtained by dividing the YFP 
FRET image by the registered CFP image. Final ratio images were Gaussian filtered.   
FRET data from Dora-Rhoa was obtained by taking a whole cell average from the ratio 
image. 
 The polarization ratio in microfluidic experiments was obtained by segmenting 
ratio images into binary images. Rows of the resulting binary images were then used to 
define the cell length. The polarization ratio was then obtained by taking the ratio 
between the mean value of the front 20% of the cell length and the rear 20% of the cell 
length from the original ratio images. We define front as where a protrusion is generated. 
  CIL outcomes in microfluidic experiments were analyzed by observing GFP time 
series and assessing the direction of migration within 60 minutes post collision. In HT 
collisions, we considered cells which did not repolarize in 60 minutes as outcome 1.  CIL 
in 2D was analyzed using a previously described metric
51, 52
 by tracking cell positions 60 
minutes before and after.  
 Cell areas under EGF stimulation were analyzed by manually segmenting cells 





4.4.7  Immunostaining 
 
 For live cell immunostaining, MTLn3-b1 cells were seeded onto collagen coated 
glass coverslips and allowed to attach overnight. Cells were subsequently starved for 3 
hours and incubated with either 1 g/ml unclustered ephrin fc or fc for 5 minutes at 37 
◦
C. Next, cells were washed thrice with cold starvation medium and then incubated with a 
FITC conugated Goat anti human IgG fc antibody on ice for 1 hour. Finally, cells were 
washed thrice in starvation medium, fixed for 15 minutes in 1% paraformaldehyde 
(Sigma) with Hoechst 33342 (Sigma), washed twice in PBS, and mounted onto slides 
(Fisher) with ProLong (Invitrogen).    
 All other immunostaining was carried out as follows- MTLn3-b1 cells were 
seeded onto collagen coated glass coverslips and allowed to attach overnight. Cells were 
subsequently starved for 3 hours and fixed for 25 minutes in 4% PFA, permeabilized in 
.1% Triton for 7 minutes, blocked with 10% Goat serum in PBS for 1 hour, incubated 
with primary antibodies for 1 hour, incubated with secondary antibodies with Hoechst 
33342 for 1 hour, and then mounted onto glass coverslides with ProLong. PBS washes 
were carried out in between steps.  
 
4.4.8  Bead preparation 
  
 5 m protein A coated silica beads were obtained from G. Kisher. To coat beads, 
either 50 g/ml fc or ephrin-fc were incubated with 1 l of beads for 1 hour at room 
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temperature under agitation. After coating, beads were centrifuged and washed thrice 
with PBS + 1% BSA to remove weakly bound ligands and left in 4 
◦
C under gentle 
agitation overnight. The protein concentration in the solutions containing ephrin-fc or fc, 
were measured using a nanodrop (Thermo Scientific) before and after the addition of 
beads to confirm that beads were coated.   
 
4.4.9  Real time RT-PCR 
 
 MTLn3 cells were harvested from cell culture dishes using RNA protect (Qiagen). 
An RNeasy Plus kit (Qiagen) was then used to extract RNA from MTLn3-b1 cells. 
cDNA was created using a Quantitect Reverse transcription kit (Qiagen). Real time RT-
PCR assays were carried out on a Quantstudio system (Applied Biosystems) using 
Taqman gene expression assays with a Taqman gene expression mastermix (Invitrogen). 
The following Taqman primers were used and obtained from Invitrogen- EGFR, ephrin-
b1, ephrin-b2, Eph-B1, Eph-B2, Eph-B3, Eph-B4, Eph-B6. All results were normalized 
to Beta Actin from the same well. Each experiment was carried out in quadruplicate in 
three independent biological replicates. EGFR was used as an endogenous control 







Chapter 5. Conclusions  
 
 
5.1 Summary of results 
 
 
This dissertation has investigated the molecular mechanisms underlying directed cell 
migration and provides new insights into the intracellular signaling enabling it. Our 
approach capitalized on principles from engineering and the life sciences. Specifically, 
we developed several new microdevices which enabled intimate control of the cellular 
microenvironment through physical confinement and the presentation of chemical 
gradients. These devices were tailored to answer specific questions in directed cell 
migration- 1) Is the graded activity of a core component sufficient in itself to induce 
directed migration? 2) How are multiple cues integrated during directed migration? We 
anticipate that the technological advances made here will be useful, as they allow the 
perturbation and characterization of new cellular behavior and can be applied to other 
fields.  
 In chapter 2, we detailed the development and rationale of two new microfluidic 
devices utilized in chapter 3 and 4. We provided new design solutions to many of the 
current issues with available chemotaxis assays. The devices are high throughput, 
function without shear stress on cells, capable of accounting for unbalanced inputs, and 
can study early gradient sensing events due to the incorporation of valves which allow 
precise temporal control of inputs across all experimental regions.  The devices increased 
in sophistication from chapter 3 to chapter 4, owing to the more stringent design 
constraints imposed by the biological questions.  
137 
 
 In chapter 3, we developed a new technique to directly establish an intracellular 
gradient of protein activity without receptor activation. We utilized this technique to address 
a fundamental question in the field of directed cell migration- Are intracellular gradients of 
small Rho GTPase activity themselves sufficient to induce direction migration? This 
technique relies on two components, a microfluidic device to generate spatial gradients of 
soluble chemicals and chemically induced dimerization (CID) technologies. We 
demonstrated the utility of this technique by imposing gradients of different steepness of the 
active form of a Rho GTPase, Rac, across living cells. We found that shallow gradients of 
Rac alone were sufficient to direct the polarity and movement of cells and could recapitulate 
phenotypes of chemoattractant induced migration, suggesting that cell polarity can be defined 
starting from a downstream node, Rac. Based on analysis of gradient steepness and cellular 
response times, we developed a refined mathematical model of cell chemotaxis and found 
that Rac activity needed to exceed a threshold in order for cells to polarize. Finally, we 
suggested a novel role for an upstream kinase, PI3K, in sensitizing cells to Rac activation.  
 In chapter 4, we explored how cells integrate multiple directional migration cues 
and how this integration might be beneficial for cell dispersion. Specifically, we looked 
at how the interactions between chemotaxis and CIL could shape directional migration 
responses. Using MTLn3-B1 cells as a model cell line exhibiting chemotaxis and CIL, 
we first characterized chemotactic responses in different EGF gradients. Subsequently, 
we found that CIL could disrupt chemotaxis, leading us to characterize CIL with and 
without external gradients of EGF. We found that EGF gradients could bias CIL 
outcomes, suggesting that these cues do not function independent of each other. The 
balance between the guidance imposed by chemotaxis and CIL could be shifted by 
augmenting or diminishing chemotactic signaling through changing external EGF inputs 
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or overexpression of EGFR, indicating that the cross regulation of these cues is dynamic. 
We next characterized some of the intracellular components involved in chemotaxis and 
found that PI3K and Rac were activated at the leading edge of MTLn3 cells. These same 
molecules were subject to downregulation upon the initiation of CIL, suggesting that they 
might be targets of regulation from CIL. As the molecular mediators of CIL in MTln3 
cells are unknown, we developed a cell collision assay where chemotaxing MTLn3 
encountered beads coated with various proteins previously shown to mediate CIL in other 
systems. We found that Eph B signaling, initiated during contact with ephrin b ligand 
coated beads, was sufficient to induce CIL and demonstrated that MTLn3 cells express 
both the ligand, ephrin b and receptors, Eph B.  Application of the exogenous ephrin b 
ligand was sufficient to induce cellular retraction, further suggesting that Eph B signaling 
was the primary mediator of CIL in MTLn3 cells. Surprisingly, we found that Eph B did 
not active RhoA, one of the downstream effectors of CIL in many systems, suggesting 
that Eph B may induce CIL by inhibiting EGF signaling. Finally, we used CID to suggest 
that the crosstalk between Eph B and EGF signaling occurs above PI3K.      
 
5.2 Future outlook and directions 
 
 We anticipate that the techniques developed in this dissertation should be 
applicable to other questions in directed cell migration and other areas of cell biology 





5.2.1  Graded Signaling 
 
The technological platform developed in Chapter 3 should be applicable to studying other 
signaling species involved in directed migration as long as the limitations of the 
technique are kept in mind. One of the main limitations is the lack of reversibility, as 
rapamycin binds to both FRB and FKBP with very high affinity. This means that the 
graded signaling across a cell will inevitably saturate and become uniform across a cell 
with continuous stimulation. However, if this saturation period is delayed, for example, 
by using lower concentrations of rapamycin, there will be a time window where graded 
signaling will be maintained. Alternatively, we showed that using a pulse of graded 
rapamycin was sufficient to induce a response. This pulse should be sufficient to induce a 
graded distribution of activators and the removal of external rapamycin should 
theoretically ensure that this distribution does not change. However, these distributions 
may evolve due to lateral diffusion of FKBP-FRB-rapamycin complexes. We suggest 
another alternative technique is to simultaneously add a gradient of a second dimerizer 
during stimulation with graded rapamycin. Our lab recently demonstrated that the 
addition of an orthogonal dimerizer could turn off rapamycin dimerization induced 
signaling
217
. A careful titration between the concentrations of both dimerizers should 
allow the maintenance of graded signaling. A second limitation of this technique is that it 
is only currently applicable to proteins activated at cell membranes. However, given that 
the vast majority of signaling in directed migration occurs at the cell membrane, we do 
not anticipate this to be a major roadblock. There is a vast and ever-expanding library of 
rapamycin activatable molecular species, including activators of other canonical 
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migration components, such as Cdc42, RhoA, Ras, PI3K etc. We suggest that graded 
activation of these components should reveal interesting signaling hierarchies and allow 
the testing of positive or negative feedbacks through the addition of pharmacological 
compounds. Molecules which can directly induce curvature, such as Bin–Amphiphysin–
Rvs (BAR) represent another interesting research area. It will be fascinating to test 
whether localized, graded curvature will be sufficient to induce cell migration. Finally, 
our technique could be used to explore how cell polarization is regulated, for example, by 
locally recruiting PAR complexes.  
 
5.2.2 Chemotaxis in Cancer 
 
We anticipate that the microdevices utilized in this dissertation will allow a more in depth 
look at the gradient sensitivity of different cancer cells and other slower migrating cells in 
general. Most current chemotaxis studies are carried out in neutrophils and dictyostelium, 
which migrate about an order of magnitude faster than their slower counterparts (cancer 
cells, fibroblasts)
36
. This faster migration allows the use of simpler chemotaxis assays, 
such as the micropipette assay. Although micropipettes have been utilized to study 




, these assays are relatively short lived and 
are low throughput. Another compounding issue is that substantial chemotaxis in these 
cell types occurs on the time scale of hours. We showed in Chapter 4, that we could assay 
chemotaxis in hundreds of MTLn3 breast cancer cells in a single experiment for over 8 
hours. This allowed us to map out the EGF gradient sensitivity of MTLn3 cells. We 
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anticipate that similar studies will be possible in other breast cancers cell lines and other 
migratory cancer cells.  
 Generally speaking, mechanistic insights into cancer cell chemotaxis are 
relatively sparse when compared to neutrophils, dictyostelium, and even fibroblasts. For 
example, it is unknown whether intracellular gradient amplification occurs or whether 
cancer cells adapt to external chemoattractants.  We believe that research in this area will 
be aided by the tools developed in this dissertation.   Many of the seminal studies carried 
out in neutrophils, dictyostelium, and fibroblasts have been carried out through the use of 
fluorescently tagged biosensors. We show in chapter 4 that our device is compatible with 
such sensors, by visualizing the activity of canonical chemotaxis mediating proteins, 
PI3K and Rac.  It will be interesting to compare chemotaxis paradigms between different 
cell types and to speculate on why these differences might occur. 
 Our microdevices currently assay chemotaxis in 1D, where cells migrate along a 
collagen coated glass coverslip. In reality, chemotaxis in vivo occurs in 3D, where a 
given cell may receive input from the ECM around the entire cell diameter. It will be of 
interest to implement gels into the microchannels of our current devices and to assess 
chemotaxis through them. A recent paper from the Sixt group recently correlated in vivo 
chemokine deposited gradients with in vivo dendritic cell guidance
218
, suggesting a 
mechanism in which long term guidance could be achieved. We propose that a similar 
assay could be carried out in vitro with MTLn3 cells by pre-depositing EGF gradients 
across collagen gel filled microchannels. Alternatively, macrophages, shown to be 
sources of EGF for cancer cells
219
, could be patterned on one side of a gel with MTLn3 
on the other. Such assays may more faithfully recreate the in vivo guidance scenarios. An 
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additional benefit to studying directed migration through collagen gels in our system 
could be the simplification of imaging. The pseudo one dimensional environment 
narrows the plane in which a chemotaxing cell could reside and thus may allow faster 
imaging. Imaging multiple Z planes is typically a rate limiting step in 4D imaging. 
 
5.2.3  Perspective on microfluidics 
 
A current trend in microfluidics is to simplify device setup and implementation in order 
to increase their use among the general scientific community. For example, in the cell 
migration community, there are a variety of companies which offer simple microfluidic 
devices for population level assays.  However, I would argue that the future of 
microfluidics should branch not only towards simplification, but also towards increased 
complexity. Adding complexity is justified in applications which require sensitive 
control, such as those presented here. More complex assays should also be possible with 
the refinement of new modules within microfluidic devices. For example, the 
development of microfluidic valves from the Quake group
116
,  greatly expanded the 
applications of microfluidics.  
 Another current trend is to use microdevices as proxies for physiological or 
pathological processes, such as in the Organ on a chip project. This necessitates a bridge 
in scale between the hundreds of cells typically used in microdevices to the level of 
tissues. We suggest that 3D printing technologies will become more and more prominent 
in this area, as the typical Z restrictions found in photolithography are absent. This 
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freedom in the Z dimension should allow the fabrication of shapes which are currently 
impossible with current microfluidic techniques.     
 
5.3  Final thoughts 
 
This dissertation represents a multi-faceted approach to studying cell biology, where 
techniques from engineering and concepts from the life sciences were integrated to allow 
the exploration of new questions in directed cell migration. We believe that similar multi-
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